Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Electron Transport Chain (OXPHOS system in mitochondria) WP111,9.35798507055562e-17,7.399336734693877,273.0926231123521,"['NDUFA12', 'COX15', 'NDUFB5', 'COX4I1', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX7A1', 'COX7C', 'ATP5MC1', 'ATP5IF1', 'COX11', 'UQCRFS1', 'NDUFV3', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'NDUFC2', 'SDHC', 'NDUFC1', 'SDHD', 'COX6C', 'ATP5F1E', 'COX6B1', 'COX7A2L', 'UQCRQ', 'NDUFS5', 'SLC25A5']",4.4637588786550305e-14,0,0,38
2,Oxidative phosphorylation WP623,8.279087913385867e-08,5.718257718966604,93.24733091359928,"['ATP5PF', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS5', 'NDUFV3', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME']",1.9745624673425293e-05,0,0,19
3,Mitochondrial CIV Assembly WP4922,4.136701036890328e-07,7.4738972640982695,109.85281458291028,"['COA3', 'COX16', 'PET100', 'COX15', 'COX4I1', 'COX7A2', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'TMEM177', 'PNKD', 'COX11', 'COX14']",6.577354648655621e-05,0,0,14
4,Nonalcoholic fatty liver disease WP4396,7.690609065925931e-06,2.7576142131979697,32.47231532997789,"['NDUFA12', 'NDUFB5', 'COX4I1', 'PRKAG1', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX7A1', 'COX7C', 'UQCRFS1', 'NDUFV3', 'NDUFV1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'NDUFC2', 'SDHC', 'NDUFC1', 'SDHD', 'COX6C', 'EIF2S1', 'NFKB1', 'COX6B1', 'COX7A2L', 'UQCRQ', 'DDIT3', 'NDUFS5']",0.0008280802645753665,0,0,30
5,Mitochondrial complex I assembly model OXPHOS system WP4324,8.68008663076904e-06,4.5229744728079915,52.71291123177198,"['NDUFA7', 'NDUFA6', 'DMAC1', 'NDUFA5', 'NDUFA12', 'NDUFB5', 'ACAD9', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'TMEM186', 'NDUFS5', 'NDUFV3', 'NDUFV1']",0.0008280802645753665,0,0,16
6,Cellular Proteostasis WP4918,0.001036291462979715,19.11860174781523,131.38507383837424,"['PFDN1', 'PFDN2', 'PFDN4', 'PFDN6']",0.08058969724060243,0,0,4
7,Cytoplasmic Ribosomal Proteins WP477,0.0011826580307845221,2.5047092322856206,16.881717195484907,"['RPL41', 'RPS8', 'RPL11', 'RPL35A', 'RPSA', 'RPL10A', 'RPL6', 'RPS4X', 'RPL7A', 'RPS14', 'RPL27', 'RPL37', 'RPS2', 'RPL15', 'RPL29', 'RPS27A', 'RPL39', 'RPS23']",0.08058969724060243,0,0,18
8,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.0035703449860404533,5.2176136363636365,29.40173835610665,"['EIF3J', 'EIF3F', 'EIF2S2', 'EIF2S1', 'EIF3D', 'EIF1']",0.21288181979266202,0,0,6
9,Mitochondrial CII Assembly WP4920,0.0041368992859145744,9.558052434456929,52.45276365387233,"['SDHAF2', 'SDHAF1', 'SDHC', 'SDHD']",0.21925566215347245,0,0,4
10,Pyrimidine metabolism WP4022,0.00965356077150238,2.145792095462349,9.957394665738315,"['DUT', 'RRM2', 'POLR3GL', 'NME2', 'NME1', 'POLE4', 'POLD1', 'POLR3D', 'POLR2D', 'TWISTNB', 'POLE3', 'POLR2E', 'TK2', 'DCTPP1', 'POLR2K']",0.4427126318548852,0,0,15
11,Mitochondrial complex III assembly WP4921,0.010209305975689175,4.780137414116178,21.914327851986442,"['UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10']",0.4427126318548852,0,0,5
12,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.013709102446813035,4.345295553915166,18.63999371744688,"['RPH3A', 'SYTL1', 'GCC2', 'SYTL2', 'EXPH5']",0.5449368222608182,0,0,5
13,Ciliary landscape WP4352,0.015306537877254034,1.6006768189509306,6.689989115427223,"['PSMD13', 'COPS7A', 'MCM10', 'PSMD8', 'EXOSC7', 'PSMD7', 'ARHGDIA', 'BBS9', 'SNRPB2', 'DCAF11', 'BBS4', 'RAB2A', 'CNOT6L', 'NDUFA5', 'EXOC6B', 'DYNLL1', 'COX6C', 'LSM4', 'NFKB1', 'AIMP1', 'COPS4', 'IFT20', 'AFG3L2', 'MKLN1', 'IFT22', 'TBC1D4', 'MFAP1', 'WNK1', 'TIPRL', 'IFT27']",0.5616321974961672,0,0,30
14,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.02148230326963066,4.777777777777778,18.34917875782977,"['ZEB1', 'JAK2', 'JAK3', 'NFKB1']",0.7319327614009874,0,0,4
15,Glycosylation and related congenital defects WP4521,0.026516499995148497,3.0191447368421054,10.95945946215717,"['DPM2', 'ALG8', 'DPM3', 'MPI', 'SRD5A3', 'ALG14']",0.7440217939815196,0,0,6
16,Photodynamic therapy-induced unfolded protein response WP3613,0.026516499995148497,3.0191447368421054,10.95945946215717,"['NARS', 'WARS', 'DDIT3', 'DNAJB11', 'PDIA6', 'HSP90B1']",0.7440217939815196,0,0,6
17,Striated Muscle Contraction Pathway WP383,0.026516499995148497,3.0191447368421054,10.95945946215717,"['MYOM1', 'ACTA1', 'TPM3', 'TNNC2', 'TPM1', 'ACTG1']",0.7440217939815196,0,0,6
18,Aspirin and miRNAs WP4707,0.03318774407989548,5.7308796007485965,19.516938149726194,"['ABCC4', 'NFKB1', 'PDK1']",0.833187048742639,0,0,3
19,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.03318774407989548,5.7308796007485965,19.516938149726194,"['UBE2V1', 'SQSTM1', 'NFKB1']",0.833187048742639,0,0,3
20,Hippo-Yap signaling pathway WP4537,0.03543076599510848,3.185717260045805,10.640852321999372,"['YWHAQ', 'NF2', 'TNIK', 'NDRG1', 'TEAD1']",0.8450237689833372,0,0,5
21,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.04425857107800507,2.606931818181818,8.12764756970589,"['ADAMTS2', 'CRTAP', 'CREB3L1', 'SERPINH1', 'PLOD2', 'PPIB']",0.9993093490438837,0,0,6
22,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.04633656767851133,4.775421085464753,14.669252293127128,"['MESP2', 'EPHA4', 'DLL3']",0.9993093490438837,0,0,3
23,Myometrial relaxation and contraction pathways WP289,0.05593882041464737,1.5552701167067897,4.4846162149907425,"['PRKCG', 'RYR2', 'PRKCB', 'IGFBP2', 'PRKCD', 'ADCY1', 'ADCY7', 'SLC8A1', 'NFKB1', 'ACTG1', 'RGS4', 'ACTA1', 'GNG3', 'RGS3', 'YWHAQ', 'PRKAR2B', 'PDE4B', 'CALM3', 'GNB5']",0.9993093490438837,0,0,19
24,Base Excision Repair WP4752,0.059405382713465675,2.389375,6.746090741842879,"['POLE4', 'FEN1', 'NEIL2', 'POLD1', 'POLE3', 'HMGB1']",0.9993093490438837,0,0,6
25,ACE Inhibitor Pathway WP554,0.061639905411513825,4.092950717404866,11.404785348653716,"['MAS1', 'REN', 'NR3C2']",0.9993093490438837,0,0,3
26,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.07413489515424182,6.36450540315877,16.559608912733232,"['MAS1', 'REN']",0.9993093490438837,0,0,2
27,Purine metabolism WP4792,0.07895593107389316,3.58109794135995,9.091925717028172,"['DGUOK', 'ITPA', 'APRT']",0.9993093490438837,0,0,3
28,Rett syndrome causing genes WP4312,0.08053004496260056,1.91188986232791,4.816289424860523,"['TRRAP', 'SATB2', 'SCN8A', 'GABRA3', 'BRAF', 'SMARCA1', 'RHOBTB2', 'SCN1A']",0.9993093490438837,0,0,8
29,Apoptosis Modulation by HSP70 WP384,0.0843575658248497,2.7290886392009988,6.748192311590799,"['CASP6', 'CASP2', 'NFKB1', 'HSPA1A']",0.9993093490438837,0,0,4
30,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.0843575658248497,2.7290886392009988,6.748192311590799,"['MDH2', 'IDH2', 'SDHC', 'SDHD']",0.9993093490438837,0,0,4
31,7-oxo-C and 7beta-HC pathways WP5064,0.09413334454648978,2.274620029148449,5.375024807683785,"['HSD11B2', 'ACOT8', 'ACOT7', 'ACOT13', 'SLC27A5']",0.9993093490438837,0,0,5
32,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.09413334454648978,2.274620029148449,5.375024807683785,"['TTC9', 'PNCK', 'TPM3', 'NR3C1', 'JAK2']",0.9993093490438837,0,0,5
33,Nucleotide metabolism WP404,0.09918471249381217,2.5469829379941737,5.8854952899074116,"['RRM2', 'POLD1', 'NME2', 'OAZ1']",0.9993093490438837,0,0,4
34,RAS and bradykinin pathways in COVID-19 WP4969,0.09918471249381217,2.5469829379941737,5.8854952899074116,"['CYP24A1', 'REN', 'KLKB1', 'NFKB1']",0.9993093490438837,0,0,4
35,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.09918471249381217,2.5469829379941737,5.8854952899074116,"['RPS6KA5', 'RAP1A', 'BRAF', 'NR3C1']",0.9993093490438837,0,0,4
36,Genes related to primary cilium development (based on CRISPR) WP4536,0.10176289057065309,1.5217565098218364,3.4773806742856723,"['MKKS', 'ARL3', 'TUBD1', 'DYNLL1', 'TXNDC15', 'IFT20', 'TMEM17', 'KIF3B', 'TTC21B', 'TMEM107', 'CEP83', 'IFT27', 'BBS9', 'BBS4']",0.9993093490438837,0,0,14
37,Translation Factors WP107,0.1062324671158203,1.7781529237127804,3.9868420134665543,"['EEF1B2', 'EIF3J', 'EIF3F', 'EIF2S2', 'EIF2S1', 'EIF3D', 'EIF4G3', 'EIF1']",0.9993093490438837,0,0,8
38,Major receptors targeted by epinephrine and norepinephrine WP4589,0.11892398858919297,2.864504054897068,6.099304672457568,"['ADRA1D', 'ADCY1', 'ADCY7']",0.9993093490438837,0,0,3
39,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.12103385832647379,1.91075,4.034902021361431,"['PRKCG', 'PLCB4', 'PRKCB', 'PRKCD', 'NFKB1', 'PDK1']",0.9993093490438837,0,0,6
40,VEGFA-VEGFR2 Signaling Pathway WP3888,0.13416035582382976,1.2114101447501961,2.433383191445924,"['NAPA', 'EPB41', 'PXN', 'CRIP2', 'TXN', 'HMGB1', 'RPL10A', 'ACACB', 'NDRG1', 'SLC8A1', 'CAMKK2', 'ACTG1', 'RND1', 'RAP1A', 'RPS6KA5', 'TMSB4X', 'AP2S1', 'RICTOR', 'ITGAV', 'ELOC', 'ATP6V1E1', 'TMSB10', 'ACP1', 'ZC3H15', 'DECR1', 'MAP2K4', 'SDF2L1', 'PRKCB', 'TPM3', 'SIAH2', 'PRKCD', 'IDH2', 'GAB1', 'PDIA6', 'NFKB1', 'DNAJA1', 'INPP4B', 'AFDN', 'TFCP2', 'FSCN1', 'RPL27', 'EIF3F', 'GRSF1', 'EIF3D', 'HSPA1A']",0.9993093490438837,0,0,45
41,"Cerebral organic acidurias, including diseases WP4519",0.1371775964033414,3.818204488778055,7.584782532740124,"['MDH2', 'IDH2']",0.9993093490438837,0,0,2
42,mRNA Processing WP411,0.14072010711277858,1.3910577472841623,2.7278397839795647,"['SNRPN', 'DHX8', 'RNMT', 'SNU13', 'PTBP2', 'LSM2', 'PRPF4', 'LSM7', 'SNRPD1', 'SNRPG', 'SNRPE', 'SNRPB2', 'SNRPD3', 'SREK1', 'TXNL4A', 'HNRNPA1']",0.9993093490438837,0,0,16
43,PKC-gamma calcium signaling pathway in ataxia WP4760,0.1500229462065076,2.1220696351782493,4.025496116056021,"['PRKCG', 'PLCB4', 'CA8', 'PDK1']",0.9993093490438837,0,0,4
44,Unfolded protein response WP4925,0.1500229462065076,2.1220696351782493,4.025496116056021,"['DDIT3', 'RTCB', 'CASP2', 'EIF2S1']",0.9993093490438837,0,0,4
45,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.1600836787686743,1.5356919223544145,2.813477605826433,"['PSMD8', 'PSMD7', 'PSMD13', 'SIAH2', 'PSMC1', 'HSPA6', 'UBE2G2', 'UBE2J2', 'HSPA1A']",0.9993093490438837,0,0,9
46,Cytosolic DNA-sensing pathway WP4655,0.16614771902505063,1.6309736268094388,2.927398702026974,"['POLR3GL', 'POLR3D', 'POLR2E', 'POLR2F', 'ISG15', 'POLR2K', 'NFKB1']",0.9993093490438837,0,0,7
47,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.17184089637754452,3.181629260182876,5.603441709848915,"['CUL2', 'ELOC']",0.9993093490438837,0,0,2
48,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.18837031242530225,1.909612983770287,3.1878038538341866,"['ITK', 'DYRK1A', 'NFKB1', 'PDK1']",0.9993093490438837,0,0,4
49,Transcription co-factors SKI and SKIL protein partners WP4533,0.18925183777180593,2.203032775085177,3.667337276919555,"['PRMT5', 'SATB2', 'TEAD1']",0.9993093490438837,0,0,3
50,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.19347788803956245,1.4984416795504185,2.461328385332329,"['PRKCG', 'PLCB4', 'CYP24A1', 'PRKCB', 'PRKCD', 'SP3', 'ISG15', 'NFKB1']",0.9993093490438837,0,0,8
51,Proteasome Degradation WP183,0.19347788803956245,1.4984416795504185,2.461328385332329,"['PSMD8', 'PSMB6', 'PSMD7', 'UBE2B', 'PSMD13', 'PSMC1', 'PSME2', 'PSMA7']",0.9993093490438837,0,0,8
52,CAMKK2  Pathway WP4874,0.19927734151702534,1.7051842598376015,2.750560683049594,"['FIS1', 'MAP1LC3A', 'MAF', 'SQSTM1', 'CAMKK2']",0.9993093490438837,0,0,5
53,Disruption of postsynaptic signaling by CNV WP4875,0.19927734151702534,1.7051842598376015,2.750560683049594,"['RPH3A', 'TJP1', 'RYR2', 'DLG1', 'HOMER1']",0.9993093490438837,0,0,5
54,Eukaryotic Transcription Initiation WP405,0.20427408268760666,1.5916666666666666,2.528032458839957,"['TAF12', 'POLR3D', 'POLR2E', 'POLR2F', 'GTF2H3', 'POLR2K']",0.9993093490438837,0,0,6
55,Chemokine signaling pathway WP3929,0.2053394560248101,1.3032969544597452,2.0632374003641654,"['VAV3', 'ITK', 'PRKCB', 'PRKCD', 'PXN', 'BRAF', 'ADCY1', 'ADCY7', 'NFKB1', 'GNG3', 'RAP1A', 'PLCB4', 'GNB5', 'JAK2', 'JAK3']",0.9993093490438837,0,0,15
56,"Degradation pathway of sphingolipids, including diseases WP4153",0.20769928586939782,2.726932668329177,4.285821868110376,"['NEU3', 'GM2A']",0.9993093490438837,0,0,2
57,Supression of HMGB1 mediated inflammation by THBD WP4479,0.20769928586939782,2.726932668329177,4.285821868110376,"['HMGB1', 'NFKB1']",0.9993093490438837,0,0,2
58,BMP Signaling Pathway in Eyelid Development WP3927,0.2146540838947142,2.045539613225203,3.147527970648701,"['TGFA', 'DKK2', 'FGF10']",0.9993093490438837,0,0,3
59,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.2146540838947142,2.045539613225203,3.147527970648701,"['CYP24A1', 'ALPL', 'NFKB1']",0.9993093490438837,0,0,3
60,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.2146540838947142,2.045539613225203,3.147527970648701,"['TJP1', 'PXN', 'ITGAV']",0.9993093490438837,0,0,3
61,Parkinson's disease pathway WP2371,0.21676377936924038,1.6462771112882035,2.51707060308982,"['CASP6', 'SYT11', 'CASP2', 'UBE2G2', 'UBE2J2']",0.9993093490438837,0,0,5
62,White fat cell differentiation WP4149,0.22941679690000338,1.7357848144364998,2.555448190556323,"['WNT10B', 'DDIT3', 'PPARG', 'NR3C1']",0.9993093490438837,0,0,4
63,DNA Repair Pathways Full Network WP4946,0.23744570559348666,1.2739530988274708,1.8317105177692847,"['FEN1', 'CENPX', 'REV1', 'FANCC', 'HMGB1', 'GTF2H3', 'GTF2H5', 'POLE4', 'NEIL2', 'RAP1A', 'POLD1', 'CHEK1', 'POLE3', 'REV3L']",0.9993093490438837,0,0,14
64,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.24071338957375393,1.909045539613225,2.718763975320151,"['RAB5C', 'MRAS', 'BRAF']",0.9993093490438837,0,0,3
65,Gene regulatory network modelling somitogenesis  WP2854,0.2442141357103237,2.3859102244389025,3.3634411044981465,"['MESP2', 'EPHA4']",0.9993093490438837,0,0,2
66,TCA cycle in senescence WP5050,0.2442141357103237,2.3859102244389025,3.3634411044981465,"['BRAF', 'PDK1']",0.9993093490438837,0,0,2
67,Gastric Cancer Network 2 WP2363,0.25071358332318927,1.6602073495087661,2.2968040519974546,"['AHCTF1', 'S100A6', 'BRIX1', 'COL9A3']",0.9993093490438837,0,0,4
68,Oxidative Stress WP408,0.25071358332318927,1.6602073495087661,2.2968040519974546,"['CAT', 'NFKB1', 'TXN2', 'SOD1']",0.9993093490438837,0,0,4
69,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.2530367092773782,1.5398641977796135,2.1161132632028647,"['MAP1LC3A', 'RICTOR', 'NFKB1', 'IGF1R', 'PDK1']",0.9993093490438837,0,0,5
70,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.2592745466399002,1.3642052565707135,1.8414966844220892,"['GNA13', 'RAP1A', 'BRAF', 'TTF2', 'TTF1', 'JAK2', 'IGF1R', 'MYL12B']",0.9993093490438837,0,0,8
71,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.2672500166366804,1.7896132252027448,2.3615211169407124,"['PRKAG1', 'ACACB', 'PDK1']",0.9993093490438837,0,0,3
72,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.2685381035642966,1.432125,1.882904191444101,"['MAP2K4', 'RPS6KA5', 'CSNK2A1', 'PRKCD', 'EIF4G3', 'PDK1']",0.9993093490438837,0,0,6
73,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.2724006649496312,1.5909280066583438,2.0689720644462923,"['EDA', 'CCND2', 'FGF1', 'NFKB1']",0.9993093490438837,0,0,4
74,PDGFR-beta pathway WP3972,0.2724006649496312,1.5909280066583438,2.0689720644462923,"['PDGFRB', 'MAP2K4', 'PRKCB', 'JAK2']",0.9993093490438837,0,0,4
75,Farnesoid X receptor pathway WP2879,0.28093818151575084,2.1206705458575783,2.6924470711811486,"['SLC27A5', 'FKBP5']",0.9993093490438837,0,0,2
76,"NAD metabolism, sirtuins and aging WP3630",0.28093818151575084,2.1206705458575783,2.6924470711811486,"['PPARG', 'NFKB1']",0.9993093490438837,0,0,2
77,Osteoblast Signaling WP322,0.28093818151575084,2.1206705458575783,2.6924470711811486,"['PDGFRB', 'ITGAV']",0.9993093490438837,0,0,2
78,Osteopontin Signaling WP1434,0.28093818151575084,2.1206705458575783,2.6924470711811486,"['ITGAV', 'NFKB1']",0.9993093490438837,0,0,2
79,Transcriptional cascade regulating adipogenesis WP4211,0.28093818151575084,2.1206705458575783,2.6924470711811486,"['DDIT3', 'PPARG']",0.9993093490438837,0,0,2
80,Vitamin B12 Disorders WP4271,0.28093818151575084,2.1206705458575783,2.6924470711811486,"['CUBN', 'MMACHC']",0.9993093490438837,0,0,2
81,Purine metabolism and related disorders WP4224,0.2940959223161916,1.6842317713111445,2.0612458717887088,"['DGUOK', 'ITPA', 'APRT']",0.9993093490438837,0,0,3
82,Pathways Regulating Hippo Signaling WP4540,0.2978207571919043,1.2564305500593589,1.52186841452955,"['PDGFRB', 'PRKCG', 'PLCB4', 'PRKCB', 'PRKAR2B', 'PRKCD', 'PRKAG1', 'NF2', 'TEAD1', 'IGF1R']",0.9993093490438837,0,0,10
83,Calcium Regulation in the Cardiac Cell WP536,0.29913662822668297,1.1939032055311125,1.4408678852134376,"['PRKCG', 'RYR2', 'PRKCB', 'PRKCD', 'ADRA1D', 'ADCY1', 'ADCY7', 'SLC8A1', 'RGS4', 'GNG3', 'RGS3', 'YWHAQ', 'PRKAR2B', 'CALM3', 'GNB5']",0.9993093490438837,0,0,15
84,G Protein Signaling Pathways WP35,0.31046366553216975,1.2400318979266347,1.4504509311930662,"['PRKCG', 'GNA13', 'GNG3', 'PRKCB', 'PRKAR2B', 'PRKCD', 'PDE4B', 'ADCY1', 'GNB5', 'ADCY7']",0.9993093490438837,0,0,10
85,16p11.2 proximal deletion syndrome WP4949,0.3160742983916991,1.272924488944514,1.4661263857991265,"['IGBP1', 'KCTD13', 'PPARG', 'NR3C1', 'SEZ6L2', 'CDIPT', 'NFKB1', 'CCT4']",0.9993093490438837,0,0,8
86,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.3165844383083629,1.4683568616152887,1.6888530886256472,"['RAP1A', 'YWHAQ', 'NDRG1', 'TEAD1']",0.9993093490438837,0,0,4
87,Genes targeted by miRNAs in adipocytes WP1992,0.3175030499832768,1.9084788029925186,2.189536381570602,"['TMSB4X', 'PTBP2']",0.9993093490438837,0,0,2
88,Pregnane X receptor pathway WP2876,0.3210957202484301,1.5905593678519443,1.8069009009818353,"['NCOA1', 'ABCC4', 'DNAJC7']",0.9993093490438837,0,0,3
89,Oncostatin M Signaling Pathway WP2374,0.32612745712359864,1.2850339154279116,1.4398380977286755,"['PRKCB', 'PRKCD', 'PXN', 'RICTOR', 'JAK2', 'JAK3', 'NFKB1']",0.9993093490438837,0,0,7
90,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.3289439050940078,3.180269989615784,3.5360405727071136,['NFKB1'],0.9993093490438837,0,0,1
91,Gastric acid production WP2596,0.3289439050940078,3.180269989615784,3.5360405727071136,['GRP'],0.9993093490438837,0,0,1
92,MED and Pseudoachondroplasia genes WP4789,0.3289439050940078,3.180269989615784,3.5360405727071136,['COL9A3'],0.9993093490438837,0,0,1
93,Nanomaterial-induced inflammasome activation WP3890,0.3289439050940078,3.180269989615784,3.5360405727071136,['NFKB1'],0.9993093490438837,0,0,1
94,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.3289439050940078,3.180269989615784,3.5360405727071136,['CCKBR'],0.9993093490438837,0,0,1
95,Vitamin B6-dependent and responsive disorders WP4228,0.3289439050940078,3.180269989615784,3.5360405727071136,['PIGV'],0.9993093490438837,0,0,1
96,Common Pathways Underlying Drug Addiction WP2636,0.3291583137996899,1.3635227982510931,1.5151689592697388,"['PRKCG', 'RAP1A', 'PRKCB', 'ADCY1', 'ACTG1']",0.9993093490438837,0,0,5
97,Nephrotic syndrome WP4758,0.3291583137996899,1.3635227982510931,1.5151689592697388,"['CUBN', 'INF2', 'NPHS1', 'ARHGDIA', 'TTC21B']",0.9993093490438837,0,0,5
98,Regulation of Actin Cytoskeleton WP51,0.32953648093376503,1.1645536631356257,1.2927340062629058,"['PDGFRB', 'PXN', 'BRK1', 'BRAF', 'ARPC5', 'FGF1', 'ACTG1', 'GNA13', 'FGF14', 'MRAS', 'ABI2', 'TMSB4X', 'FGF22', 'FGF10', 'ARHGEF6']",0.9993093490438837,0,0,15
99,PI3K-Akt signaling pathway WP4172,0.3462760537419797,1.100637886161052,1.1672473671120438,"['LAMA1', 'TNC', 'TGFA', 'LAMC1', 'FGF1', 'EFNA5', 'IGF1R', 'HSP90B1', 'GNG3', 'CCND2', 'CREB3L4', 'CREB3L1', 'ITGAV', 'JAK2', 'JAK3', 'FGF22', 'PDGFRB', 'PPP2R5A', 'NFKB1', 'EFNA2', 'FGF14', 'CDC37', 'ITGA10', 'ITGA8', 'COL9A3', 'PKN2', 'GNB5', 'FGF10']",0.9993093490438837,0,0,28
100,1q21.1 copy number variation syndrome WP4905,0.3481072059387186,1.5067472173884493,1.5899871413635895,"['TJP1', 'AFDN', 'PRKAG1']",0.9993093490438837,0,0,3
101,Fatty Acid Biosynthesis WP357,0.3481072059387186,1.5067472173884493,1.5899871413635895,"['MECR', 'ACACB', 'DECR1']",0.9993093490438837,0,0,3
102,IL-6 signaling pathway WP364,0.34860368684121956,1.3255604136303698,1.396901504856467,"['NCOA1', 'MAP2K4', 'PRKCD', 'GAB1', 'JAK2']",0.9993093490438837,0,0,5
103,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.34860368684121956,1.3255604136303698,1.396901504856467,"['ACTA1', 'YWHAQ', 'NF2', 'TEAD1', 'ACTG1']",0.9993093490438837,0,0,5
104,Splicing factor NOVA regulated synaptic proteins WP4148,0.34860368684121956,1.3255604136303698,1.396901504856467,"['PLCB4', 'CADM1', 'EPB41', 'EFNA5', 'NEO1']",0.9993093490438837,0,0,5
105,Wnt signaling WP428,0.34995623676807003,1.1799302595893064,1.2388644369971917,"['PRKCG', 'WNT10B', 'WNT10A', 'CCND2', 'SFRP2', 'PLCB4', 'CSNK2A1', 'PRKCB', 'PRICKLE2', 'ROR1', 'DKK2']",0.9993093490438837,0,0,11
106,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.3501945948475949,1.145769956002514,1.2022177951932187,"['VAV3', 'CSNK2A1', 'PRKCD', 'EIF2S2', 'ACACB', 'EIF2S1', 'NFKB1', 'GRIP1', 'DLG1', 'RPS6KA5', 'RAP1A', 'DPYSL2', 'ALPL', 'JAK2', 'SQSTM1']",0.9993093490438837,0,0,15
107,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.3536083273520587,1.7348673770120153,1.8035080957675782,"['TNC', 'VHL']",0.9993093490438837,0,0,2
108,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.3536083273520587,1.7348673770120153,1.8035080957675782,"['RYR2', 'CCKBR']",0.9993093490438837,0,0,2
109,Development and heterogeneity of the ILC family WP3893,0.3536083273520587,1.7348673770120153,1.8035080957675782,"['IL15', 'ZBTB16']",0.9993093490438837,0,0,2
110,Nephrogenesis WP5052,0.3536083273520587,1.7348673770120153,1.8035080957675782,"['GREB1L', 'RSPO3']",0.9993093490438837,0,0,2
111,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.3536083273520587,1.7348673770120153,1.8035080957675782,"['UBE2V1', 'NFKB1']",0.9993093490438837,0,0,2
112,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.35437351645260173,1.2725833333333334,1.3201827742183694,"['VAV3', 'HELLS', 'BEX3', 'SQSTM1', 'NFKB1', 'HSPD1']",0.9993093490438837,0,0,6
113,G1 to S cell cycle control WP45,0.35793553461446853,1.237277928334839,1.2711822879282493,"['CDKN2D', 'CCND2', 'ORC6', 'TFDP2', 'CREB3L4', 'CREB3L1', 'CDK1']",0.9993093490438837,0,0,7
114,Glioblastoma signaling pathways WP2261,0.3614262630038192,1.1931747025673136,1.2142905936251096,"['PRKCG', 'PDGFRB', 'MAP2K4', 'CCND2', 'PRKCB', 'PRKCD', 'GAB1', 'BRAF', 'IGF1R']",0.9993093490438837,0,0,9
115,DNA Mismatch Repair WP531,0.3750015356434353,1.431316281971304,1.4038710183708971,"['POLE4', 'POLD1', 'POLE3']",0.9993093490438837,0,0,3
116,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.37531411374218326,1.1767526440843705,1.1532081383342159,"['PRKCG', 'PDGFRB', 'MRAS', 'PRKCB', 'GAB1', 'TGFA', 'BRAF', 'JAK2', 'IGF1R']",0.9993093490438837,0,0,9
117,Alpha 6 Beta 4 signaling pathway WP244,0.3836273176238742,1.316199578113565,1.261029394223741,"['LAMA1', 'PRKCD', 'GAB1', 'LAMC1']",0.9993093490438837,0,0,4
118,Amyotrophic lateral sclerosis (ALS) WP2447,0.3836273176238742,1.316199578113565,1.261029394223741,"['CCS', 'ALS2', 'CAT', 'SOD1']",0.9993093490438837,0,0,4
119,BDNF-TrkB Signaling WP3676,0.3836273176238742,1.316199578113565,1.261029394223741,"['HOMER1', 'GAB1', 'BRAF', 'ADCY1']",0.9993093490438837,0,0,4
120,Type 2 papillary renal cell carcinoma WP4241,0.3836273176238742,1.316199578113565,1.261029394223741,"['CUL2', 'TGFA', 'ELOC', 'VHL']",0.9993093490438837,0,0,4
121,Fatty acid transporters WP5061,0.3890119907832413,1.5901911886949294,1.5013712366846885,"['FABP3', 'FABP5']",0.9993093490438837,0,0,2
122,FOXA2 pathway WP5066,0.3890119907832413,1.5901911886949294,1.5013712366846885,"['ABCC4', 'SLC27A5']",0.9993093490438837,0,0,2
123,Galanin receptor pathway WP4970,0.3890119907832413,1.5901911886949294,1.5013712366846885,"['PRKCD', 'PPARG']",0.9993093490438837,0,0,2
124,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.3890119907832413,1.5901911886949294,1.5013712366846885,"['TERT', 'ALPL']",0.9993093490438837,0,0,2
125,IL-1 signaling pathway WP195,0.3894113698220024,1.2182712765957446,1.1489747736874591,"['MAP2K4', 'IL1R1', 'PELI2', 'UBE2V1', 'SQSTM1', 'NFKB1']",0.9993093490438837,0,0,6
126,Amino Acid Metabolism Pathway Excerpt (Histidine catabolism extension) WP4661,0.3926461421297934,2.385046728971963,2.229652525914363,['UROC1'],0.9993093490438837,0,0,1
127,Mitochondrial fatty acid synthesis pathway WP4317,0.3926461421297934,2.385046728971963,2.229652525914363,['MECR'],0.9993093490438837,0,0,1
128,Canonical and non-canonical Notch signaling WP3845,0.4016631311688136,1.363069245165315,1.2433120583757693,"['MAML2', 'MFAP1', 'DLL3']",0.9993093490438837,0,0,3
129,p38 MAPK Signaling Pathway WP400,0.4058757828010278,1.2722430295464002,1.1471918702101416,"['MAP2K4', 'RPS6KA5', 'DDIT3', 'HMGN1']",0.9993093490438837,0,0,4
130,Tryptophan metabolism WP465,0.4058757828010278,1.2722430295464002,1.1471918702101416,"['AANAT', 'WARS', 'AFMID', 'CAT']",0.9993093490438837,0,0,4
131,Nucleotide Excision Repair WP4753,0.40709324762013893,1.2233539934976536,1.0994441499745105,"['POLE4', 'POLD1', 'POLE3', 'GTF2H3', 'GTF2H5']",0.9993093490438837,0,0,5
132,Biomarkers for pyrimidine metabolism disorders WP4584,0.42352204175883784,1.4677728755035488,1.2610366544082698,"['RRM2', 'TK2']",0.9993093490438837,0,0,2
133,Blood Clotting Cascade WP272,0.42352204175883784,1.4677728755035488,1.2610366544082698,"['F8', 'KLKB1']",0.9993093490438837,0,0,2
134,Hypertrophy Model WP516,0.42352204175883784,1.4677728755035488,1.2610366544082698,"['ZEB1', 'IL1R1']",0.9993093490438837,0,0,2
135,Endochondral Ossification with Skeletal Dysplasias WP4808,0.42441124119949597,1.1683928571428572,1.0013738852029435,"['ACAN', 'SERPINH1', 'COL10A1', 'ALPL', 'IGF1R', 'SOX5']",0.9993093490438837,0,0,6
136,Endochondral Ossification WP474,0.42441124119949597,1.1683928571428572,1.0013738852029435,"['ACAN', 'SERPINH1', 'COL10A1', 'ALPL', 'IGF1R', 'SOX5']",0.9993093490438837,0,0,6
137,Oxysterols derived from cholesterol WP4545,0.4279625886822152,1.2311223873384076,1.0448775731324997,"['ACOT8', 'ACOT7', 'ACOT13', 'SLC27A5']",0.9993093490438837,0,0,4
138,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.4279625886822152,1.2311223873384076,1.0448775731324997,"['CREB3L4', 'CREB3L1', 'CALM3', 'REN']",0.9993093490438837,0,0,4
139,Cannabinoid receptor signaling WP3869,0.4279893732273739,1.301026484432598,1.1041251195109816,"['PRKAR2B', 'ADCY1', 'ADCY7']",0.9993093490438837,0,0,3
140,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.44174584875773587,1.0787030213706705,0.8813225520872582,"['RYR2', 'CDCA7L', 'NR3C1', 'ASCL1', 'NFKB1', 'GCK', 'HSP90B1', 'HSPD1', 'YWHAQ', 'PRKAR2B', 'SP3', 'SCN5A', 'SCN3B']",0.9993093490438837,0,0,13
141,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.44574321098075265,1.1635258451272832,0.9401431394384797,"['MAP1LC3A', 'PPP1R7', 'PPP1R3E', 'DDIT3', 'EIF2S1']",0.9993093490438837,0,0,5
142,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.45030462864211496,1.9079127725856697,1.5221919031954776,['PPARG'],0.9993093490438837,0,0,1
143,FTO Obesity Variant Mechanism WP3407,0.45030462864211496,1.9079127725856697,1.5221919031954776,['ARID5B'],0.9993093490438837,0,0,1
144,"Phase I biotransformations, non P450 WP136",0.45030462864211496,1.9079127725856697,1.5221919031954776,['ESD'],0.9993093490438837,0,0,1
145,Pilocytic astrocytoma WP2253,0.45030462864211496,1.9079127725856697,1.5221919031954776,['BRAF'],0.9993093490438837,0,0,1
146,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.45030462864211496,1.9079127725856697,1.5221919031954776,['IGF1R'],0.9993093490438837,0,0,1
147,Ras signaling WP4223,0.4517777440808307,1.0602375960866528,0.8424276184401113,"['PDGFRB', 'PRKCG', 'RAB5C', 'PRKCB', 'PLA2G4C', 'GAB1', 'STK4', 'NFKB1', 'IGF1R', 'AFDN', 'GNG3', 'RAP1A', 'MRAS', 'ABL2', 'CALM3', 'GNB5']",0.9993093490438837,0,0,16
148,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.4539886341387171,1.1131123618928498,0.8790060386101749,"['RYR2', 'ITGA10', 'ITGA8', 'ITGAV', 'DSG2', 'SLC8A1', 'ACTG1']",0.9993093490438837,0,0,7
149,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.4569892002804752,1.3628428927680798,1.067236163979354,"['RBBP4', 'THRAP3']",0.9993093490438837,0,0,2
150,NOTCH1 regulation of endothelial cell calcification WP3413,0.4569892002804752,1.3628428927680798,1.067236163979354,"['ALPL', 'DLL3']",0.9993093490438837,0,0,2
151,Overview of interferons-mediated signaling pathway WP4558,0.4569892002804752,1.3628428927680798,1.067236163979354,"['IFNE', 'JAK2']",0.9993093490438837,0,0,2
152,3q29 copy number variation syndrome WP4906,0.45910891265641623,1.1224264705882352,0.8737728815999037,"['DLG1', 'CEP350', 'PXN', 'WDR53', 'NF2', 'DYNLL1']",0.9993093490438837,0,0,6
153,Focal Adhesion WP306,0.4732169107993312,1.0408289443553926,0.7787496841610375,"['PRKCG', 'VAV3', 'PDGFRB', 'PRKCB', 'LAMA1', 'PXN', 'TNC', 'BRAF', 'LAMC1', 'MYL12B', 'ACTG1', 'IGF1R', 'MYL7', 'CCND2', 'RAP1A', 'ITGA10', 'ITGA8', 'ITGAV']",0.9993093490438837,0,0,18
154,AGE/RAGE pathway WP2324,0.4762688524939644,1.1007692307692307,0.8165206392760435,"['PRKCB', 'PRKCD', 'ALPL', 'JAK2', 'NFKB1', 'SOD1']",0.9993093490438837,0,0,6
155,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.4762688524939644,1.1007692307692307,0.8165206392760435,"['MAP2K4', 'ACTA1', 'TMSB4X', 'TGFA', 'PFN2', 'SOD1']",0.9993093490438837,0,0,6
156,Intraflagellar transport proteins binding to dynein WP4532,0.4792871915880854,1.192451653150343,0.8769948839345029,"['IFT22', 'IFT27', 'DYNLL1']",0.9993093490438837,0,0,3
157,Type II interferon signaling (IFNG) WP619,0.4792871915880854,1.192451653150343,0.8769948839345029,"['PRKCD', 'ISG15', 'JAK2']",0.9993093490438837,0,0,3
158,Phosphoinositides metabolism WP4971,0.4837283709237377,1.109263105907645,0.8055820831822204,"['MTMR10', 'PLCB4', 'MTMR3', 'INPP5D', 'MTM1']",0.9993093490438837,0,0,5
159,Apoptosis WP254,0.48552586570382855,1.0770642942161432,0.7782034194285684,"['HRK', 'HELLS', 'MAP2K4', 'CASP6', 'CASP2', 'NFKB1', 'IGF1R']",0.9993093490438837,0,0,7
160,Pyrimidine metabolism and related diseases WP4225,0.48930053394957584,1.27190357439734,0.9091291884252551,"['RRM2', 'TK2']",0.9993093490438837,0,0,2
161,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4926851713515424,1.1222736285525445,0.7944405627208267,"['MAP2K4', 'ACTA1', 'CASP6', 'ACTG1']",0.9993093490438837,0,0,4
162,Glycolysis and Gluconeogenesis WP534,0.4926851713515424,1.1222736285525445,0.7944405627208267,"['MPC1', 'MDH2', 'MPC2', 'GCK']",0.9993093490438837,0,0,4
163,Prostaglandin Synthesis and Regulation WP98,0.4926851713515424,1.1222736285525445,0.7944405627208267,"['HSD11B2', 'ABCC4', 'S100A6', 'PPARG']",0.9993093490438837,0,0,4
164,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.5011005391434717,1.0598985477034257,0.7323353340486644,"['WNT10B', 'WNT10A', 'CCND2', 'SFRP2', 'CSNK2A1', 'ROR1', 'DKK2']",0.9993093490438837,0,0,7
165,Non-small cell lung cancer WP4255,0.5011005391434717,1.0598985477034257,0.7323353340486644,"['PRKCG', 'PRKCB', 'TGFA', 'BRAF', 'STK4', 'JAK3', 'PDK1']",0.9993093490438837,0,0,7
166,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5023810736725571,1.0839816024075861,0.7462089637875343,"['ITK', 'DLG1', 'CHP1', 'NFKB1', 'PDK1']",0.9993093490438837,0,0,5
167,Benzo(a)pyrene metabolism WP696,0.5024924410695876,1.5898234683281411,1.0940762594502087,['AKR1A1'],0.9993093490438837,0,0,1
168,Dual hijack model of Vif in HIV infection WP3300,0.5024924410695876,1.5898234683281411,1.0940762594502087,['ELOC'],0.9993093490438837,0,0,1
169,Glial Cell Differentiation WP2276,0.5024924410695876,1.5898234683281411,1.0940762594502087,['GAP43'],0.9993093490438837,0,0,1
170,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5024924410695876,1.5898234683281411,1.0940762594502087,['TBC1D4'],0.9993093490438837,0,0,1
171,Insulin signaling in adipocytes (normal condition) WP3634,0.5024924410695876,1.5898234683281411,1.0940762594502087,['TBC1D4'],0.9993093490438837,0,0,1
172,Mevalonate pathway WP3963,0.5024924410695876,1.5898234683281411,1.0940762594502087,['PMVK'],0.9993093490438837,0,0,1
173,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.5024924410695876,1.5898234683281411,1.0940762594502087,['HIF1AN'],0.9993093490438837,0,0,1
174,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.5024924410695876,1.5898234683281411,1.0940762594502087,['NFKB1'],0.9993093490438837,0,0,1
175,Aryl Hydrocarbon Receptor Pathway WP2873,0.5041135626404695,1.144678727386151,0.7840519451937914,"['NCOA1', 'CDC37', 'CAP2']",0.9993093490438837,0,0,3
176,MAPK Signaling Pathway WP382,0.5177537928701111,1.0088141025641026,0.6640573841312488,"['PRKCG', 'PDGFRB', 'MAP2K4', 'PPP5D1', 'IL1R1', 'PRKCD', 'HSPA6', 'PLA2G4C', 'BRAF', 'FGF1', 'STK4', 'NFKB1', 'RPS6KA5', 'MRAS', 'RAP1A', 'FGF14', 'DDIT3', 'STMN1', 'RAPGEF2', 'FGF22', 'HSPA1A', 'FGF10']",0.9993093490438837,0,0,22
177,15q13.3 copy number variation syndrome WP4942,0.5203739103565201,1.1923316708229426,0.7788401894980144,"['MTMR10', 'SERPINH1']",0.9993093490438837,0,0,2
178,IL1 and megakaryocytes in obesity WP2865,0.5203739103565201,1.1923316708229426,0.7788401894980144,"['IL1R1', 'NFKB1']",0.9993093490438837,0,0,2
179,Transcription factor regulation in adipogenesis WP3599,0.5203739103565201,1.1923316708229426,0.7788401894980144,"['PPARG', 'NR3C1']",0.9993093490438837,0,0,2
180,Integrin-mediated Cell Adhesion WP185,0.5270777438987576,1.0219160926737634,0.6544424436672052,"['VAV3', 'RAP1A', 'CAPN7', 'ITGA10', 'PXN', 'ITGA8', 'RHO', 'BRAF', 'ITGAV']",0.9993093490438837,0,0,9
181,Pathways in clear cell renal cell carcinoma WP4018,0.5362813154193119,1.0173383395911557,0.6338998706060543,"['PDGFRB', 'PBRM1', 'ZEB1', 'EFCAB3', 'PLOD2', 'VHL', 'SQSTM1', 'ACACB']",0.9993093490438837,0,0,8
182,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5388505831971562,1.0367161828205198,0.6410191960979981,"['TKFC', 'IFNE', 'PIN1', 'ISG15', 'NFKB1']",0.9993093490438837,0,0,5
183,Pathogenic Escherichia coli infection WP2272,0.5388505831971562,1.0367161828205198,0.6410191960979981,"['YWHAQ', 'ARPC3', 'ARHGEF2', 'ARPC5', 'ACTG1']",0.9993093490438837,0,0,5
184,Phosphodiesterases in neuronal function WP4222,0.5388505831971562,1.0367161828205198,0.6410191960979981,"['PDE11A', 'PDE10A', 'PDE4B', 'ADCY1', 'ADCY7']",0.9993093490438837,0,0,5
185,Canonical NF-KB pathway WP4562,0.5497283471343342,1.3626168224299064,0.8152959364971631,['NFKB1'],0.9993093490438837,0,0,1
186,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.5497283471343342,1.3626168224299064,0.8152959364971631,['HSD11B2'],0.9993093490438837,0,0,1
187,Heme Biosynthesis WP561,0.5497283471343342,1.3626168224299064,0.8152959364971631,['ALAD'],0.9993093490438837,0,0,1
188,HIF1A and PPARG regulation of glycolysis WP2456,0.5497283471343342,1.3626168224299064,0.8152959364971631,['PPARG'],0.9993093490438837,0,0,1
189,NAD Biosynthesis II (from tryptophan) WP2485,0.5497283471343342,1.3626168224299064,0.8152959364971631,['AFMID'],0.9993093490438837,0,0,1
190,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.5497283471343342,1.3626168224299064,0.8152959364971631,['NFKB1'],0.9993093490438837,0,0,1
191,Vitamin D Metabolism WP1531,0.5497283471343342,1.3626168224299064,0.8152959364971631,['CYP24A1'],0.9993093490438837,0,0,1
192,GABA receptor Signaling WP4159,0.5518381368012388,1.0597490815831427,0.6300213653804904,"['GABRQ', 'GABRA3', 'AP2S1']",0.9993093490438837,0,0,3
193,Genes controlling nephrogenesis WP4823,0.5518381368012388,1.0597490815831427,0.6300213653804904,"['PDGFRB', 'NPHS1', 'ITGA8']",0.9993093490438837,0,0,3
194,Metabolic reprogramming in colon cancer WP4290,0.5541262494571658,1.0310760198400648,0.6087088550345776,"['MDH2', 'IDH2', 'PYCR1', 'PYCR2']",0.9993093490438837,0,0,4
195,Ciliopathies WP4803,0.5721320940389721,0.9779067892275439,0.5460488547223487,"['DNAH11', 'MKKS', 'ARL3', 'DCDC2', 'RSPH3', 'RSPH1', 'TMEM17', 'CSPP1', 'TTC21B', 'TMEM107', 'CEP83', 'IFT27', 'BBS9', 'NEK2', 'CCNO', 'BBS4']",0.9993093490438837,0,0,16
196,Cardiac Progenitor Differentiation WP2406,0.5746519268737876,1.0218340611353711,0.5660866343014135,"['MESP2', 'MESP1', 'SCN5A']",0.9993093490438837,0,0,3
197,Fluoropyrimidine Activity WP1601,0.5746519268737876,1.0218340611353711,0.5660866343014135,"['ABCC4', 'RRM2', 'GGH']",0.9993093490438837,0,0,3
198,Zinc homeostasis WP3529,0.5746519268737876,1.0218340611353711,0.5660866343014135,"['SLC30A9', 'SLC30A3', 'SLC39A10']",0.9993093490438837,0,0,3
199,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.578603960570607,1.0597118315322804,0.5798075962102887,"['H3F3B', 'H2AFY']",0.9993093490438837,0,0,2
200,Triacylglyceride synthesis WP325,0.578603960570607,1.0597118315322804,0.5798075962102887,"['DGAT2', 'AGPAT1']",0.9993093490438837,0,0,2
201,Urea cycle and metabolism of amino groups WP497,0.578603960570607,1.0597118315322804,0.5798075962102887,"['PYCR1', 'PYCR3']",0.9993093490438837,0,0,2
202,Vitamin D in inflammatory diseases WP4482,0.578603960570607,1.0597118315322804,0.5798075962102887,"['NR3C1', 'NFKB1']",0.9993093490438837,0,0,2
203,Apoptosis Modulation and Signaling WP1772,0.5906588125690919,0.967352783895732,0.5093274279948976,"['HRK', 'TNFRSF6B', 'CASP6', 'IL1R1', 'CASP2', 'NFKB1', 'HSPA1A']",0.9993093490438837,0,0,7
204,ATR Signaling WP3875,0.5924819490456256,1.1922118380062305,0.6240452510415178,['CHEK1'],0.9993093490438837,0,0,1
205,Biotin Metabolism (including IEMs) WP5031,0.5924819490456256,1.1922118380062305,0.6240452510415178,['ACACB'],0.9993093490438837,0,0,1
206,Cytosine methylation WP3585,0.5924819490456256,1.1922118380062305,0.6240452510415178,['IDH2'],0.9993093490438837,0,0,1
207,Leptin and adiponectin WP3934,0.5924819490456256,1.1922118380062305,0.6240452510415178,['PRKAG1'],0.9993093490438837,0,0,1
208,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5924819490456256,1.1922118380062305,0.6240452510415178,['CHI3L1'],0.9993093490438837,0,0,1
209,PTF1A related regulatory pathway WP4147,0.5924819490456256,1.1922118380062305,0.6240452510415178,['FGF10'],0.9993093490438837,0,0,1
210,Role of Osx and miRNAs in tooth development WP3971,0.5924819490456256,1.1922118380062305,0.6240452510415178,['ALPL'],0.9993093490438837,0,0,1
211,Serotonin Transporter Activity WP1455,0.5924819490456256,1.1922118380062305,0.6240452510415178,['IL1R1'],0.9993093490438837,0,0,1
212,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.5924819490456256,1.1922118380062305,0.6240452510415178,['CCND2'],0.9993093490438837,0,0,1
213,Thiamine metabolic pathways WP4297,0.5924819490456256,1.1922118380062305,0.6240452510415178,['SLC25A19'],0.9993093490438837,0,0,1
214,Regulation of Microtubule Cytoskeleton WP2038,0.5927929733857947,0.978072281443068,0.5114438337436175,"['DPYSL2', 'STMN1', 'RHO', 'CDK1']",0.9993093490438837,0,0,4
215,miRNA regulation of prostate cancer signaling pathways WP3981,0.5967246760008752,0.9865338696839977,0.509346895501546,"['PDGFRB', 'CREB3L1', 'NFKB1']",0.9993093490438837,0,0,3
216,Glycerolipids and Glycerophospholipids WP4722,0.6057100711031329,1.00387189919937,0.5032950294437488,"['DGAT2', 'CDIPT']",0.9993093490438837,0,0,2
217,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6057780516809752,0.9535,0.4779338764229456,"['PDGFRB', 'PRKCB', 'STMN1', 'RICTOR', 'JAK2', 'JAK3']",0.9993093490438837,0,0,6
218,ATM Signaling Network in Development and Disease  WP3878,0.6113629328926555,0.9535580524344569,0.4692120643563959,"['CHEK1', 'CDK1', 'NFKB1', 'HMGN1']",0.9993093490438837,0,0,4
219,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6113629328926555,0.9535580524344569,0.4692120643563959,"['TMEM43', 'BANF1', 'ADCY1', 'ADCY7']",0.9993093490438837,0,0,4
220,Melatonin metabolism and effects WP3298,0.6180343959159595,0.9535870243293824,0.45887672409963814,"['AANAT', 'CRY2', 'NFKB1']",0.9993093490438837,0,0,3
221,Nuclear receptors WP170,0.6180343959159595,0.9535870243293824,0.45887672409963814,"['ROR1', 'PPARG', 'NR3C1']",0.9993093490438837,0,0,3
222,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6180343959159595,0.9535870243293824,0.45887672409963814,"['IGFBP2', 'TGFA', 'HIF1AN']",0.9993093490438837,0,0,3
223,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6186645166844781,0.9399800931920479,0.4513710426345526,"['WNT10B', 'WNT10A', 'CCND2', 'SFRP2', 'CSNK2A1', 'ROR1', 'DKK2']",0.9993093490438837,0,0,7
224,ESC Pluripotency Pathways WP3931,0.6288837639471476,0.9325637744684326,0.4325313171978855,"['PDGFRB', 'WNT10B', 'WNT10A', 'FGF14', 'GAB1', 'BRAF', 'FGF1', 'FGF22', 'FGF10']",0.9993093490438837,0,0,9
225,Autosomal recessive Osteopetrosis pathways WP4788,0.6311783406346021,1.0596746278989269,0.487627108654015,['NFKB1'],0.9993093490438837,0,0,1
226,Cytokines and Inflammatory Response WP530,0.6311783406346021,1.0596746278989269,0.487627108654015,['IL15'],0.9993093490438837,0,0,1
227,Dopamine metabolism WP2436,0.6311783406346021,1.0596746278989269,0.487627108654015,['SOD1'],0.9993093490438837,0,0,1
228,EDA signaling in hair follicle development WP3930,0.6311783406346021,1.0596746278989269,0.487627108654015,['EDA'],0.9993093490438837,0,0,1
229,LTF danger signal response pathway WP4478,0.6311783406346021,1.0596746278989269,0.487627108654015,['NFKB1'],0.9993093490438837,0,0,1
230,Constitutive Androstane Receptor Pathway WP2875,0.6314703366387101,0.9536159600997506,0.43838136804422917,"['NCOA1', 'DNAJC7']",0.9993093490438837,0,0,2
231,Estrogen signaling pathway WP712,0.6314703366387101,0.9536159600997506,0.43838136804422917,"['BRAF', 'NFKB1']",0.9993093490438837,0,0,2
232,Urea cycle and associated pathways WP4595,0.6314703366387101,0.9536159600997506,0.43838136804422917,"['MDH2', 'PYCR1']",0.9993093490438837,0,0,2
233,Pre-implantation embryo WP3527,0.6385658580604366,0.9227657819008713,0.41388856419306247,"['BATF3', 'DDIT3', 'NR3C2']",0.9993093490438837,0,0,3
234,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6385658580604366,0.9227657819008713,0.41388856419306247,"['RAP1A', 'PXN', 'GAB1']",0.9993093490438837,0,0,3
235,Cell cycle WP179,0.6393589921049965,0.9254325133221403,0.41393594945136003,"['CDKN2D', 'STAG1', 'CCND2', 'ORC6', 'STAG2', 'YWHAQ', 'TFDP2', 'CDC27', 'CHEK1', 'CDK1']",0.9993093490438837,0,0,10
236,MET in type 1 papillary renal cell carcinoma WP4205,0.6398725169419487,0.9167347330995052,0.40930951258312737,"['RAP1A', 'RPL11', 'GAB1', 'BRAF', 'JAK3']",0.9993093490438837,0,0,5
237,Notch Signaling Pathway Netpath WP61,0.6398725169419487,0.9167347330995052,0.40930951258312737,"['NUMBL', 'MAML2', 'JAK2', 'NFKB1', 'DLL3']",0.9993093490438837,0,0,5
238,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.6411285376713936,0.9405431638194443,0.41809524652141994,"['PDGFRB', 'RAB2A', 'LAMA1', 'TNC', 'PPP2R5A', 'LAMC1', 'FGF1', 'EFNA5', 'IGF1R', 'HSP90B1', 'GNG3', 'EFNA2', 'FGF14', 'CREB3L4', 'CREB3L1', 'CDC37', 'ITGA10', 'ITGA8', 'ITGAV', 'JAK2', 'JAK3', 'FGF22', 'FGF10']",0.9993093490438837,0,0,23
239,Proximal tubule transport WP4917,0.6468912224882742,0.9080316271327508,0.3955178051924466,"['ABCC4', 'ATP6V1G1', 'SLC47A1', 'ATP6V1E1']",0.9993093490438837,0,0,4
240,Hippo-Merlin Signaling Dysregulation WP4541,0.652433848479842,0.9126020863587311,0.38972263851323896,"['PDGFRB', 'PLCB4', 'PRKAR2B', 'ITGA10', 'ITGA8', 'ITGAV', 'NF2', 'TEAD1', 'IGF1R']",0.9993093490438837,0,0,9
241,Osteoblast differentiation WP4787,0.652433848479842,0.9126020863587311,0.38972263851323896,"['PRKCG', 'WNT10B', 'WNT10A', 'PRKCB', 'PRKCD', 'PPARG', 'FGF1', 'FGF10', 'DLL3']",0.9993093490438837,0,0,9
242,EPO Receptor Signaling WP581,0.6558959150105049,0.9081463009143808,0.38301358011682646,"['JAK2', 'PDK1']",0.9993093490438837,0,0,2
243,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6558959150105049,0.9081463009143808,0.38301358011682646,"['TGFBR3', 'FBN1']",0.9993093490438837,0,0,2
244,Sphingolipid Metabolism (general overview) WP4725,0.6558959150105049,0.9081463009143808,0.38301358011682646,"['ASAH1', 'SGPL1']",0.9993093490438837,0,0,2
245,TLR4 Signaling and Tolerance WP3851,0.6558959150105049,0.9081463009143808,0.38301358011682646,"['INPP5D', 'NFKB1']",0.9993093490438837,0,0,2
246,Selenium Micronutrient Network WP15,0.6634954830772124,0.893671875,0.3666139024812263,"['CAT', 'SELENOW', 'TXN', 'NFKB1', 'SELENOH', 'SOD1']",0.9993093490438837,0,0,6
247,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6638264176591505,0.8868565455970734,0.3633757967754638,"['MAP2K4', 'RPS6KA5', 'IL1R1', 'NFKB1']",0.9993093490438837,0,0,4
248,Biogenic Amine Synthesis WP550,0.6662023234025806,0.9536448598130841,0.38733417546114945,['AANAT'],0.9993093490438837,0,0,1
249,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.6662023234025806,0.9536448598130841,0.38733417546114945,['BATF3'],0.9993093490438837,0,0,1
250,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.6662023234025806,0.9536448598130841,0.38733417546114945,['PMVK'],0.9993093490438837,0,0,1
251,Retinoblastoma gene in cancer WP2446,0.6713655554397719,0.8896143422972691,0.35445927149338263,"['RRM2', 'TFDP2', 'RBBP4', 'STMN1', 'CHEK1', 'CDK1', 'HMGB1']",0.9993093490438837,0,0,7
252,Head and Neck Squamous Cell Carcinoma WP4674,0.677062532502775,0.8798653846153847,0.34314014720322755,"['TERT', 'SESN1', 'GAB1', 'RICTOR', 'NFKB1', 'IGF1R']",0.9993093490438837,0,0,6
253,Differentiation Pathway WP2848,0.677262751054181,0.8667271593035785,0.3377600815056873,"['NT5E', 'FGF1', 'FGF10']",0.9993093490438837,0,0,3
254,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.677262751054181,0.8667271593035785,0.3377600815056873,"['GABRQ', 'GABRA3', 'JAK2']",0.9993093490438837,0,0,3
255,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6790079637723835,0.8668102471094989,0.3355616829811957,"['RBBP4', 'H3F3B']",0.9993093490438837,0,0,2
256,miRNAs involvement in the immune response in sepsis WP4329,0.6790079637723835,0.8668102471094989,0.3355616829811957,"['ELANE', 'NFKB1']",0.9993093490438837,0,0,2
257,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.6790079637723835,0.8668102471094989,0.3355616829811957,"['CYP24A1', 'PPARG']",0.9993093490438837,0,0,2
258,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6790079637723835,0.8668102471094989,0.3355616829811957,"['ASCL1', 'SOX5']",0.9993093490438837,0,0,2
259,Sphingolipid Metabolism (integrated pathway) WP4726,0.6790079637723835,0.8668102471094989,0.3355616829811957,"['ASAH1', 'SGPL1']",0.9993093490438837,0,0,2
260,IL-4 signaling pathway WP395,0.6801989525970437,0.8666439677675633,0.33397853928149646,"['INPP5D', 'JAK2', 'JAK3', 'NFKB1']",0.9993093490438837,0,0,4
261,Development of ureteric collection system WP5053,0.6954254332127296,0.8411801401783421,0.30554311279516805,"['GRIP1', 'GREB1L', 'ITGA8']",0.9993093490438837,0,0,3
262,Copper homeostasis WP3286,0.6960049711604107,0.8473297267304758,0.3070710018072479,"['CCS', 'COX11', 'ATOX1', 'SOD1']",0.9993093490438837,0,0,4
263,Drug Induction of Bile Acid Pathway WP2289,0.697902223396274,0.8668932313792127,0.3118009214594451,['ABCC4'],0.9993093490438837,0,0,1
264,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.697902223396274,0.8668932313792127,0.3118009214594451,['NFKB1'],0.9993093490438837,0,0,1
265,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.697902223396274,0.8668932313792127,0.3118009214594451,['ITGAV'],0.9993093490438837,0,0,1
266,NO metabolism in cystic fibrosis WP4947,0.697902223396274,0.8668932313792127,0.3118009214594451,['PRMT5'],0.9993093490438837,0,0,1
267,Osteoclast Signaling WP12,0.697902223396274,0.8668932313792127,0.3118009214594451,['ATP6V1G1'],0.9993093490438837,0,0,1
268,Serotonin and anxiety-related events WP3944,0.697902223396274,0.8668932313792127,0.3118009214594451,['PRKCB'],0.9993093490438837,0,0,1
269,Cell migration and invasion through p75NTR WP4561,0.7008356442103623,0.8290686327659114,0.29471887496535953,"['EFNA2', 'EFNA5']",0.9993093490438837,0,0,2
270,Monoamine Transport WP727,0.7008356442103623,0.8290686327659114,0.29471887496535953,"['IL1R1', 'AMPH']",0.9993093490438837,0,0,2
271,Wnt Signaling Pathway WP363,0.7112432485029101,0.8288552353036964,0.282424784378683,"['PRKCG', 'PRKCB', 'PPARG', 'ROR1']",0.9993093490438837,0,0,4
272,7q11.23 copy number variation syndrome WP4932,0.7126872665062592,0.856520088312638,0.29011412138732584,"['GRIP1', 'DNAJC30', 'ATP5MC2', 'SQSTM1', 'ACACB', 'ATP5F1E', 'ATP5MC1', 'FBN1']",0.9993093490438837,0,0,8
273,ATM Signaling Pathway WP2516,0.7128031515520218,0.8170929507174048,0.2766268033214037,"['CHEK1', 'CDK1', 'CASP2']",0.9993093490438837,0,0,3
274,Lung fibrosis WP3624,0.7128031515520218,0.8170929507174048,0.2766268033214037,"['TERT', 'TGFA', 'FGF1']",0.9993093490438837,0,0,3
275,Vitamin A and carotenoid metabolism WP716,0.7128031515520218,0.8170929507174048,0.2766268033214037,"['SDR16C5', 'CYP26B1', 'RBP4']",0.9993093490438837,0,0,3
276,Vitamin B12 metabolism WP1533,0.7128031515520218,0.8170929507174048,0.2766268033214037,"['CUBN', 'NFKB1', 'SOD1']",0.9993093490438837,0,0,3
277,Nuclear Receptors Meta-Pathway WP2882,0.7140341305221333,0.8967280134670609,0.30203997905987023,"['NCOA1', 'ABCC4', 'MGST3', 'TGFA', 'SLC39A10', 'SERPINB9', 'TXN', 'SMARCA1', 'NR3C1', 'CES4A', 'TGFBR3', 'GSTA4', 'DNAJC7', 'CDC37', 'CDK1', 'PDE4B', 'SQSTM1', 'SLC27A5', 'CAP2', 'HSPA1A', 'FKBP5']",0.9993093490438837,0,0,21
278,NRF2 pathway WP2884,0.7176985348014565,0.8575078271759549,0.2844402049716598,"['ABCC4', 'GSTA4', 'MGST3', 'TGFA', 'SLC39A10', 'TXN', 'SQSTM1', 'CES4A', 'HSPA1A']",0.9993093490438837,0,0,9
279,EGF/EGFR signaling pathway WP437,0.7207005365017929,0.8720458343280019,0.28562254352670974,"['VAV3', 'PRKCB', 'PRKCD', 'GAB1', 'BRAF', 'NEDD8', 'RPS6KA5', 'RAP1A', 'INPP5D', 'STMN1', 'AP2S1', 'RICTOR', 'JAK2']",0.9993093490438837,0,0,13
280,SARS-CoV-2 mitochondrial interactions WP5038,0.7214144132350276,0.794472152950956,0.2594281533039961,"['ACAD9', 'NFKB1']",0.9993093490438837,0,0,2
281,Signal transduction through IL1R WP4496,0.7214144132350276,0.794472152950956,0.2594281533039961,"['IL1R1', 'NFKB1']",0.9993093490438837,0,0,2
282,Ganglio Sphingolipid Metabolism WP1423,0.7265933468389877,0.7946002076843198,0.25378602206914624,['ST3GAL5'],0.9993093490438837,0,0,1
283,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.7265933468389877,0.7946002076843198,0.25378602206914624,['H2AFY'],0.9993093490438837,0,0,1
284,Hedgehog Signaling Pathway Netpath WP47,0.7265933468389877,0.7946002076843198,0.25378602206914624,['STK36'],0.9993093490438837,0,0,1
285,Homologous recombination WP186,0.7265933468389877,0.7946002076843198,0.25378602206914624,['POLD1'],0.9993093490438837,0,0,1
286,IL-9 signaling pathway WP22,0.7265933468389877,0.7946002076843198,0.25378602206914624,['JAK3'],0.9993093490438837,0,0,1
287,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.7265933468389877,0.7946002076843198,0.25378602206914624,['STAG1'],0.9993093490438837,0,0,1
288,Glycogen Synthesis and Degradation WP500,0.7294047627756595,0.794343938448742,0.25063653958888504,"['PPP2R5A', 'PHKA1', 'CALM3']",0.9993093490438837,0,0,3
289,PDGF Pathway WP2526,0.7294047627756595,0.794343938448742,0.25063653958888504,"['PDGFRB', 'MAP2K4', 'NFKB1']",0.9993093490438837,0,0,3
290,ErbB signaling pathway WP673,0.7305034625515261,0.833739837398374,0.26181207412806307,"['PRKCG', 'MAP2K4', 'PRKCB', 'GAB1', 'TGFA', 'ABL2', 'BRAF']",0.9993093490438837,0,0,7
291,Senescence and Autophagy in Cancer WP615,0.7305034625515261,0.833739837398374,0.26181207412806307,"['GABARAPL1', 'MAP1LC3A', 'COL10A1', 'BRAF', 'SQSTM1', 'GABARAP', 'IGF1R']",0.9993093490438837,0,0,7
292,IL17 signaling pathway WP2112,0.7407845668609063,0.762643391521197,0.22882766353594478,"['JAK2', 'NFKB1']",0.9993093490438837,0,0,2
293,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.7407845668609063,0.762643391521197,0.22882766353594478,"['HSPB8', 'NDRG1']",0.9993093490438837,0,0,2
294,Lipid Metabolism Pathway WP3965,0.7407845668609063,0.762643391521197,0.22882766353594478,"['PRKAR2B', 'PRKAG1']",0.9993093490438837,0,0,2
295,Monoamine GPCRs WP58,0.7407845668609063,0.762643391521197,0.22882766353594478,"['ADRA1D', 'HTR5A']",0.9993093490438837,0,0,2
296,Resistin as a regulator of inflammation WP4481,0.7407845668609063,0.762643391521197,0.22882766353594478,"['PLCB4', 'NFKB1']",0.9993093490438837,0,0,2
297,DNA Replication WP466,0.7452422694661031,0.7728246025189257,0.22724592090041545,"['ORC6', 'POLD1', 'MCM10']",0.9993093490438837,0,0,3
298,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7510601047292137,0.7940870289402456,0.22732297414841046,"['INF2', 'YWHAQ', 'NPHS1', 'KRT8', 'ITGAV']",0.9993093490438837,0,0,5
299,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.7510601047292137,0.7940870289402456,0.22732297414841046,"['RBP4', 'SEC24B', 'PRKAG1', 'PPARG', 'SEC24D']",0.9993093490438837,0,0,5
300,Cell Differentiation - Index expanded WP2023,0.7525611083861465,0.7334291876347951,0.2084941730296406,['PAX7'],0.9993093490438837,0,0,1
301,Kennedy pathway from sphingolipids WP3933,0.7525611083861465,0.7334291876347951,0.2084941730296406,['SGPL1'],0.9993093490438837,0,0,1
302,Leptin Insulin Overlap WP3935,0.7525611083861465,0.7334291876347951,0.2084941730296406,['JAK2'],0.9993093490438837,0,0,1
303,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7525611083861465,0.7334291876347951,0.2084941730296406,['TEAD1'],0.9993093490438837,0,0,1
304,Phytochemical activity on NRF2 transcriptional activation WP3,0.7525611083861465,0.7334291876347951,0.2084941730296406,['MAF'],0.9993093490438837,0,0,1
305,PPAR signaling pathway WP3942,0.7535738336461234,0.777956126270733,0.2201057872664328,"['FABP3', 'FABP5', 'PPARG', 'SLC27A5']",0.9993093490438837,0,0,4
306,Thermogenesis WP4321,0.7539519020469126,0.8194651917046846,0.23143885264222355,"['CREB3L4', 'CREB3L1', 'PRKAG1', 'PPARG', 'ADCY1', 'ADCY7', 'MGLL', 'ACTG1']",0.9993093490438837,0,0,8
307,Endothelin Pathways WP2197,0.7589900042846544,0.7332629963552657,0.2022094956620444,"['RIIAD1', 'GNB5']",0.9993093490438837,0,0,2
308,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7589900042846544,0.7332629963552657,0.2022094956620444,"['TGFBR3', 'TGFA']",0.9993093490438837,0,0,2
309,Wnt signaling pathway and pluripotency WP399,0.7722042441072525,0.793829476756306,0.20520984072434117,"['PRKCG', 'MAP2K4', 'WNT10B', 'WNT10A', 'CCND2', 'PRKCB', 'PRKCD']",0.9993093490438837,0,0,7
310,Notch Signaling WP268,0.7746859693204171,0.7330965977254187,0.18715775257268405,"['NUMBL', 'DTX4', 'DLL3']",0.9993093490438837,0,0,3
311,Cholesterol Biosynthesis Pathway WP197,0.7760638634084103,0.6809968847352025,0.1726466461859923,['PMVK'],0.9993093490438837,0,0,1
312,Dopaminergic Neurogenesis WP2855,0.7760638634084103,0.6809968847352025,0.1726466461859923,['ASCL1'],0.9993093490438837,0,0,1
313,ERK Pathway in Huntington's Disease WP3853,0.7760638634084103,0.6809968847352025,0.1726466461859923,['RPS6KA5'],0.9993093490438837,0,0,1
314,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.7760638634084103,0.6809968847352025,0.1726466461859923,['SOD1'],0.9993093490438837,0,0,1
315,Tryptophan catabolism leading to NAD+ production WP4210,0.7760638634084103,0.6809968847352025,0.1726466461859923,['AFMID'],0.9993093490438837,0,0,1
316,Type II diabetes mellitus WP1584,0.7760638634084103,0.6809968847352025,0.1726466461859923,['PRKCD'],0.9993093490438837,0,0,1
317,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.7760771813810261,0.7060589267571811,0.17898827018836727,"['RICTOR', 'PDK1']",0.9993093490438837,0,0,2
318,Sphingolipid pathway WP1422,0.7760771813810261,0.7060589267571811,0.17898827018836727,"['ASAH1', 'SGPL1']",0.9993093490438837,0,0,2
319,Hepatitis B infection WP4666,0.7844688473917814,0.8069963043201224,0.19589707599722042,"['PRKCG', 'MAP2K4', 'YWHAQ', 'CREB3L4', 'PRKCB', 'CREB3L1', 'BRAF', 'JAK2', 'JAK3', 'NFKB1']",0.9993093490438837,0,0,10
320,IL-3 signaling pathway WP286,0.7883279241185259,0.7147223955084218,0.16999038099117214,"['YWHAQ', 'INPP5D', 'JAK2']",0.9993093490438837,0,0,3
321,Netrin-UNC5B signaling pathway WP4747,0.7883279241185259,0.7147223955084218,0.16999038099117214,"['INPP5D', 'ALPL', 'NEO1']",0.9993093490438837,0,0,3
322,Peptide GPCRs WP24,0.7883279241185259,0.7147223955084218,0.16999038099117214,"['CCKBR', 'TACR2', 'FPR2']",0.9993093490438837,0,0,3
323,Prion disease pathway WP3995,0.7920942309044433,0.6807980049875312,0.15867693770995964,"['NFKB1', 'HSP90B1']",0.9993093490438837,0,0,2
324,Tumor suppressor activity of SMARCB1 WP4204,0.7920942309044433,0.6807980049875312,0.15867693770995964,"['RBBP4', 'H3F3B']",0.9993093490438837,0,0,2
325,Cancer immunotherapy by PD-1 blockade WP4585,0.7973354718600255,0.6355555555555555,0.14394047635245183,['NFKB1'],0.9993093490438837,0,0,1
326,MAPK pathway in congenital thyroid cancer WP4928,0.7973354718600255,0.6355555555555555,0.14394047635245183,['BRAF'],0.9993093490438837,0,0,1
327,NAD+ metabolism WP3644,0.7973354718600255,0.6355555555555555,0.14394047635245183,['NT5E'],0.9993093490438837,0,0,1
328,Serotonin and anxiety WP3947,0.7973354718600255,0.6355555555555555,0.14394047635245183,['PRKCB'],0.9993093490438837,0,0,1
329,Neural Crest Differentiation WP2064,0.8023172457048197,0.7519736842105263,0.16562309211973164,"['PAX7', 'HDAC11', 'ASCL1', 'NFKB1', 'SOX5', 'DLL3']",0.9993093490438837,0,0,6
330,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8023172457048197,0.7519736842105263,0.16562309211973164,"['TBC1D4', 'ITGAV', 'PPARG', 'TTF2', 'TTF1', 'MGLL']",0.9993093490438837,0,0,6
331,The influence of laminopathies on Wnt signaling WP4844,0.8070902265568639,0.6572792157537192,0.14086795799043572,"['WNT10B', 'PPARG']",0.9993093490438837,0,0,2
332,Wnt signaling in kidney disease WP4150,0.8070902265568639,0.6572792157537192,0.14086795799043572,"['WNT10B', 'WNT10A']",0.9993093490438837,0,0,2
333,"GPCRs, Other WP117",0.8132491881924722,0.7056919591251676,0.1458790270651524,"['CCKBR', 'GPR61', 'ADRA1D', 'MCHR2']",0.9993093490438837,0,0,4
334,Energy Metabolism WP1541,0.8135534314906088,0.6805988771054273,0.1404372724706796,"['NCOA1', 'PRKAG1', 'PPARG']",0.9993093490438837,0,0,3
335,GDNF/RET signaling axis WP4830,0.8165876195457887,0.5957943925233645,0.12072049206358249,['IFT27'],0.9993093490438837,0,0,1
336,"GPCRs, Class B Secretin-like WP334",0.8165876195457887,0.5957943925233645,0.12072049206358249,['ADGRE5'],0.9993093490438837,0,0,1
337,PPAR-alpha pathway WP2878,0.8165876195457887,0.5957943925233645,0.12072049206358249,['CDK1'],0.9993093490438837,0,0,1
338,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.8165876195457887,0.5957943925233645,0.12072049206358249,['TNC'],0.9993093490438837,0,0,1
339,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8211145711253404,0.6353283458021612,0.12521853367614236,"['SUPT4H1', 'NFKB1']",0.9993093490438837,0,0,2
340,TYROBP causal network in microglia WP3945,0.8251810070227925,0.6647274731970578,0.12772905527303283,"['ABCC4', 'MAF', 'SFT2D2']",0.9993093490438837,0,0,3
341,Breast cancer pathway WP4262,0.828955757575589,0.7676449187484841,0.14400135400148617,"['NCOA1', 'WNT10B', 'WNT10A', 'CSNK2A1', 'BRAF', 'FGF1', 'FGF22', 'IGF1R', 'FGF10', 'DLL3']",0.9993093490438837,0,0,10
342,p53 transcriptional gene network WP4963,0.8335566355693147,0.6803995006242197,0.12386919894315684,"['SIVA1', 'SESN1', 'FANCC', 'ISG15']",0.9993093490438837,0,0,4
343,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.8340119192960149,0.5607110133773135,0.10177330192307979,['NFKB1'],0.9993093490438837,0,0,1
344,Kynurenine Pathway and links to Cellular Senescence WP5044,0.8340119192960149,0.5607110133773135,0.10177330192307979,['AFMID'],0.9993093490438837,0,0,1
345,Nanomaterial induced apoptosis WP2507,0.8340119192960149,0.5607110133773135,0.10177330192307979,['CASP6'],0.9993093490438837,0,0,1
346,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.8340119192960149,0.5607110133773135,0.10177330192307979,['CDC37'],0.9993093490438837,0,0,1
347,MAPK Cascade WP422,0.8342164922742074,0.6147936610087684,0.11143892977093453,"['MAP2K4', 'BRAF']",0.9993093490438837,0,0,2
348,IL-18 signaling pathway WP4754,0.834988804820167,0.8045205063417964,0.14508478367640057,"['NRN1', 'PRKCB', 'EPB41', 'HSPB8', 'PRKCD', 'NDUFC1', 'BPGM', 'ACACB', 'NFKB1', 'SLC4A7', 'ACTA1', 'ALS2', 'NACA', 'TMSB4X', 'STMN1', 'ITM2C', 'ABCF1']",0.9993093490438837,0,0,17
349,Exercise-induced Circadian Regulation WP410,0.8361824357936782,0.6495774967390688,0.1162149128864967,"['DNAJA1', 'STBD1', 'CRY2']",0.9993093490438837,0,0,3
350,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8361824357936782,0.6495774967390688,0.1162149128864967,"['TGFBR3', 'NFKB1', 'FBN1']",0.9993093490438837,0,0,3
351,DNA damage response (only ATM dependent) WP710,0.8409686249221492,0.7244201539005357,0.12547024188541056,"['WNT10B', 'WNT10A', 'CCND2', 'CAT', 'HMGB1', 'NFKB1', 'PDK1']",0.9993093490438837,0,0,7
352,Glucocorticoid Receptor Pathway WP2880,0.8429989831335017,0.6684188623869286,0.11415894149756706,"['TGFBR3', 'PDE4B', 'SERPINB9', 'NR3C1']",0.9993093490438837,0,0,4
353,Joubert Syndrome WP4656,0.8430932549104202,0.6901031058486996,0.11778521392556567,"['TMEM17', 'CSPP1', 'ARL3', 'BBS9', 'BBS4']",0.9993093490438837,0,0,5
354,Target Of Rapamycin (TOR) Signaling WP1471,0.8464446311313271,0.5955423940149626,0.0992831635630632,"['PRKAG1', 'RICTOR']",0.9993093490438837,0,0,2
355,Folate Metabolism WP176,0.8465813139860655,0.6351008525681014,0.10577542648392568,"['CAT', 'NFKB1', 'SOD1']",0.9993093490438837,0,0,3
356,Synaptic Vesicle Pathway WP2267,0.8465813139860655,0.6351008525681014,0.10577542648392568,"['NAPA', 'AP2S1', 'SYP']",0.9993093490438837,0,0,3
357,Ebstein-Barr virus LMP1 signaling WP262,0.8497818134561893,0.5295257874697127,0.0861939055708778,['NFKB1'],0.9993093490438837,0,0,1
358,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.8497818134561893,0.5295257874697127,0.0861939055708778,['ZFX'],0.9993093490438837,0,0,1
359,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.8497818134561893,0.5295257874697127,0.0861939055708778,['MAP1LC3A'],0.9993093490438837,0,0,1
360,Imatinib and Chronic Myeloid Leukemia WP3640,0.8497818134561893,0.5295257874697127,0.0861939055708778,['PDGFRB'],0.9993093490438837,0,0,1
361,Inflammatory Response Pathway WP453,0.8497818134561893,0.5295257874697127,0.0861939055708778,['LAMC1'],0.9993093490438837,0,0,1
362,miRNA targets in ECM and membrane receptors WP2911,0.8497818134561893,0.5295257874697127,0.0861939055708778,['LAMC1'],0.9993093490438837,0,0,1
363,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.8497818134561893,0.5295257874697127,0.0861939055708778,['NFKB1'],0.9993093490438837,0,0,1
364,T-cell receptor (TCR) signaling pathway WP69,0.8513345000663037,0.6801998750780762,0.10947827912129553,"['VAV3', 'ITK', 'DBNL', 'PRKCD', 'NFKB1']",0.9993093490438837,0,0,5
365,Bladder cancer WP2828,0.857846710383714,0.5774578704753268,0.08854153136500299,"['RPS6KA5', 'BRAF']",0.9993093490438837,0,0,2
366,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.857846710383714,0.5774578704753268,0.08854153136500299,"['MAP2K4', 'DDIT3']",0.9993093490438837,0,0,2
367,Globo Sphingolipid Metabolism WP1424,0.8640542957882273,0.5016232169208067,0.07329701882303714,['ST6GAL2'],0.9993093490438837,0,0,1
368,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8640542957882273,0.5016232169208067,0.07329701882303714,['SGPL1'],0.9993093490438837,0,0,1
369,Methionine De Novo and Salvage Pathway WP3580,0.8640542957882273,0.5016232169208067,0.07329701882303714,['TXN'],0.9993093490438837,0,0,1
370,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.8640542957882273,0.5016232169208067,0.07329701882303714,['NFKB1'],0.9993093490438837,0,0,1
371,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.8640542957882273,0.5016232169208067,0.07329701882303714,['CYP24A1'],0.9993093490438837,0,0,1
372,"Relationship between inflammation, COX-2 and EGFR WP4483",0.8640542957882273,0.5016232169208067,0.07329701882303714,['BRAF'],0.9993093490438837,0,0,1
373,B Cell Receptor Signaling Pathway WP23,0.8669914871491514,0.68,0.09705376227562719,"['PRKCB', 'INPP5D', 'PRKCD', 'GAB1', 'BRAF', 'NFKB1']",0.9993093490438837,0,0,6
374,IL-2 signaling pathway WP49,0.8684692703321899,0.5604371424380226,0.07903456994896102,"['CCND2', 'JAK3']",0.9993093490438837,0,0,2
375,DNA damage response WP707,0.8686543931651218,0.6348730753225135,0.08939643913089493,"['CCND2', 'SESN1', 'CHEK1', 'CDK1']",0.9993093490438837,0,0,4
376,RANKL/RANK signaling pathway WP2018,0.8744013638078856,0.5952900810979413,0.07989732399781062,"['TRAF5', 'SQSTM1', 'NFKB1']",0.9993093490438837,0,0,3
377,Fragile X Syndrome  WP4549,0.8767263468001442,0.6984418596640296,0.09188726850141574,"['GRIP1', 'EPHA4', 'HOMER1', 'GAB1', 'AP2S1', 'BRAF', 'GRIP2', 'PDK1']",0.9993093490438837,0,0,8
378,Differentiation of white and brown adipocyte WP2895,0.8769714710644562,0.47651090342679125,0.06255674084575914,['PPARG'],0.9993093490438837,0,0,1
379,IL-7 signaling pathway WP205,0.8769714710644562,0.47651090342679125,0.06255674084575914,['JAK3'],0.9993093490438837,0,0,1
380,Immune response to tuberculosis WP4197,0.8769714710644562,0.47651090342679125,0.06255674084575914,['JAK2'],0.9993093490438837,0,0,1
381,Kallmann's Syndrome WP5074,0.8769714710644562,0.47651090342679125,0.06255674084575914,['ASCL1'],0.9993093490438837,0,0,1
382,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8769714710644562,0.47651090342679125,0.06255674084575914,['MDH2'],0.9993093490438837,0,0,1
383,Oxidation by Cytochrome P450 WP43,0.8783574637747178,0.5443890274314215,0.07060814642429424,"['CYP26B1', 'CYP24A1']",0.9993093490438837,0,0,2
384,Oxidative Damage WP3941,0.8783574637747178,0.5443890274314215,0.07060814642429424,"['MAP2K4', 'NFKB1']",0.9993093490438837,0,0,2
385,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8783574637747178,0.5443890274314215,0.07060814642429424,"['TRAF5', 'NFKB1']",0.9993093490438837,0,0,2
386,Gastrin signaling pathway WP4659,0.8807788727267943,0.6797998749218261,0.0862996970033539,"['TJP1', 'CCKBR', 'PRKCD', 'PXN', 'PPARG', 'JAK2', 'NFKB1']",0.9993093490438837,0,0,7
387,Endoderm differentiation WP2853,0.8823456044303761,0.6920468767777904,0.08662451654811887,"['VAV3', 'SESN1', 'SIAH2', 'TCEAL2', 'RTF1', 'LAMC1', 'NR3C1', 'NME1']",0.9993093490438837,0,0,8
388,Acute viral myocarditis WP4298,0.8836813956894153,0.6143127542185172,0.07596511254072685,"['CASP6', 'KRT8', 'CASP2', 'ABL2']",0.9993093490438837,0,0,4
389,MECP2 and Associated Rett Syndrome WP3584,0.8836813956894153,0.6143127542185172,0.07596511254072685,"['PRPF38A', 'SP3', 'IGF1R', 'FKBP5']",0.9993093490438837,0,0,4
390,miRNA regulation of DNA damage response WP1530,0.8836813956894153,0.6143127542185172,0.07596511254072685,"['CCND2', 'SESN1', 'CHEK1', 'CDK1']",0.9993093490438837,0,0,4
391,Integrated breast cancer pathway WP1984,0.8869848177311173,0.7098903976358808,0.08513531907518403,"['UBE2F', 'RAP1A', 'RALGAPA1', 'ZMYND8', 'DCAKD', 'CHEK1', 'RHO', 'BRAF', 'CCNB1IP1', 'NFKB1']",0.9993093490438837,0,0,10
392,Corticotropin-releasing hormone signaling pathway WP2355,0.8873054414830286,0.6346450135332085,0.07588196729323375,"['PRKCB', 'PRKCD', 'BRAF', 'GNB5', 'NFKB1']",0.9993093490438837,0,0,5
393,Ferroptosis WP4313,0.8875548997476287,0.5292324743696315,0.06312944313926107,"['MAP1LC3A', 'LPCAT3']",0.9993093490438837,0,0,2
394,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.8886619653333568,0.4537902388369678,0.053564654327557124,['FPR2'],0.9993093490438837,0,0,1
395,Nanoparticle triggered autophagic cell death WP2509,0.8886619653333568,0.4537902388369678,0.053564654327557124,['MAP1LC3A'],0.9993093490438837,0,0,1
396,NRF2-ARE regulation WP4357,0.8886619653333568,0.4537902388369678,0.053564654327557124,['MAF'],0.9993093490438837,0,0,1
397,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8886619653333568,0.4537902388369678,0.053564654327557124,['ABCC4'],0.9993093490438837,0,0,1
398,Modulators of TCR signaling and T cell activation WP5072,0.8903718288770811,0.5714036182158453,0.06634917010052278,"['GNA13', 'ITK', 'NFKB1']",0.9993093490438837,0,0,3
399,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8961035300446851,0.5148951944463166,0.05648365566646907,"['JAK2', 'NFKB1']",0.9993093490438837,0,0,2
400,Adipogenesis WP236,0.8973429725029621,0.6594777676641961,0.07143274234120826,"['NCOA1', 'WNT10B', 'CYP26B1', 'DDIT3', 'CISD1', 'PPARG', 'NR3C1']",0.9993093490438837,0,0,7
401,Prader-Willi and Angelman Syndrome WP3998,0.8976540779532984,0.5601629298007412,0.06048107091427024,"['CCND2', 'SNRPN', 'BBS4']",0.9993093490438837,0,0,3
402,Spinal Cord Injury WP2431,0.8976872481482808,0.6415870786516854,0.06924876933039506,"['EPHA4', 'ACAN', 'GAP43', 'IL1R1', 'NCAN', 'CDK1']",0.9993093490438837,0,0,6
403,Aryl Hydrocarbon Receptor Netpath WP2586,0.9040435707408588,0.5013125082031763,0.05057126385230336,"['CDC37', 'NFKB1']",0.9993093490438837,0,0,2
404,Physiological and pathological hypertrophy of the heart WP1528,0.9088175708603821,0.4142760395503183,0.03960930377551939,['PRKCB'],0.9993093490438837,0,0,1
405,Signal Transduction of S1P Receptor WP26,0.9088175708603821,0.4142760395503183,0.03960930377551939,['ASAH1'],0.9993093490438837,0,0,1
406,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9088175708603821,0.4142760395503183,0.03960930377551939,['ZBTB16'],0.9993093490438837,0,0,1
407,Circadian rhythm related genes WP3594,0.9088805838202275,0.7042148798736001,0.06728179127534589,"['PRKCG', 'PRMT5', 'AANAT', 'HOMER1', 'THRAP3', 'CAVIN3', 'CRY2', 'DYRK1A', 'PPARG', 'ADCY1', 'CARTPT', 'RPS27A']",0.9993093490438837,0,0,12
408,Kit receptor signaling pathway WP304,0.9109247176605278,0.5389540837345073,0.05028173319194398,"['PRKCB', 'INPP5D', 'JAK2']",0.9993093490438837,0,0,3
409,Hepatitis C and Hepatocellular Carcinoma WP3646,0.911413453589322,0.48842636997250466,0.04530576523616375,"['RRM2', 'NFKB1']",0.9993093490438837,0,0,2
410,Ovarian infertility WP34,0.917483449206215,0.3969885773624091,0.03418894935069944,['CCND2'],0.9993093490438837,0,0,1
411,Integrated Cancer Pathway WP1971,0.9182498023789379,0.4761845386533666,0.04061178384913256,"['CHEK1', 'CDK1']",0.9993093490438837,0,0,2
412,Complement system WP2806,0.920115902921763,0.5598883748255856,0.04661386242008757,"['TXN', 'LAMC1', 'KLKB1', 'ELANE']",0.9993093490438837,0,0,4
413,Pancreatic adenocarcinoma pathway WP4263,0.9203646313279974,0.5874029348940862,0.04874583759127206,"['PRKCD', 'TGFA', 'BRAF', 'NFKB1', 'ARHGEF6']",0.9993093490438837,0,0,5
414,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9245874297311911,0.4645398698376011,0.03642348550821922,"['MAP2K4', 'TRAF5']",0.9993093490438837,0,0,2
415,TGF-beta Receptor Signaling WP560,0.9245874297311911,0.4645398698376011,0.03642348550821922,"['TGFBR3', 'NFKB1']",0.9993093490438837,0,0,2
416,Leptin signaling pathway WP2034,0.9250803499614182,0.5517378639020065,0.04296640982647866,"['NCOA1', 'JAK2', 'ACACB', 'NFKB1']",0.9993093490438837,0,0,4
417,Prolactin Signaling Pathway WP2037,0.9250803499614182,0.5517378639020065,0.04296640982647866,"['PXN', 'JAK2', 'PPIB', 'NFKB1']",0.9993093490438837,0,0,4
418,16p11.2 distal deletion syndrome WP4950,0.9253261758743374,0.3810841121495327,0.029575549641922404,['JAK2'],0.9993093490438837,0,0,1
419,Toll-like Receptor Signaling related to MyD88 WP3858,0.9253261758743374,0.3810841121495327,0.029575549641922404,['NFKB1'],0.9993093490438837,0,0,1
420,TNF-alpha signaling pathway WP231,0.9293027287050466,0.5731733931353146,0.04202549052460186,"['MAP2K4', 'CSNK2A1', 'CDC37', 'TXN', 'NFKB1']",0.9993093490438837,0,0,5
421,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9304593507790027,0.4534497090606816,0.03268324444095738,"['PMVK', 'TM7SF2']",0.9993093490438837,0,0,2
422,Complement and Coagulation Cascades WP558,0.9304593507790027,0.4534497090606816,0.03268324444095738,"['F8', 'KLKB1']",0.9993093490438837,0,0,2
423,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9304593507790027,0.4534497090606816,0.03268324444095738,"['TRAF5', 'NFKB1']",0.9993093490438837,0,0,2
424,Nanoparticle-mediated activation of receptor signaling WP2643,0.9324238954743267,0.36640306733764677,0.025636396099498505,['PXN'],0.9993093490438837,0,0,1
425,Glycerophospholipid Biosynthetic Pathway WP2533,0.9388473388159094,0.3528095073266413,0.02226312364283977,['CDIPT'],0.9993093490438837,0,0,1
426,Vitamin D Receptor Pathway WP2877,0.9391530034549288,0.5996709655246241,0.037645466288176825,"['CDKN2D', 'CYP24A1', 'ADGRE5', 'TPM1', 'S100A6', 'EFNA5', 'SLC8A1']",0.9993093490438837,0,0,7
427,Histone Modifications WP2369,0.9409293224171065,0.43278168215824075,0.02635088701032584,"['KMT2E', 'H3F3B']",0.9993093490438837,0,0,2
428,One-carbon metabolism and related pathways WP3940,0.9409293224171065,0.43278168215824075,0.02635088701032584,"['GPX7', 'SOD1']",0.9993093490438837,0,0,2
429,Small cell lung cancer WP4658,0.9410360846560095,0.5530700289063522,0.03361216344843345,"['LAMA1', 'TRAF5', 'ITGAV', 'LAMC1', 'NFKB1']",0.9993093490438837,0,0,5
430,AMP-activated protein kinase (AMPK) signaling WP1403,0.9418797614314904,0.48395487274918847,0.02897808258912882,"['PRKAG1', 'ACACB', 'CAMKK2']",0.9993093490438837,0,0,3
431,Alzheimer's disease WP2059,0.942272832953501,0.5213688368990816,0.031000807282584496,"['ATP5MD', 'PLCB4', 'CHP1', 'CALM3']",0.9993093490438837,0,0,4
432,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.942272832953501,0.5213688368990816,0.031000807282584496,"['MAP2K4', 'PRKCB', 'NFKB1', 'IGF1R']",0.9993093490438837,0,0,4
433,Autophagy WP4923,0.9446605250942007,0.3401869158878505,0.019366721624877216,['PRKAG1'],0.9993093490438837,0,0,1
434,Heart Development WP1591,0.9446605250942007,0.3401869158878505,0.019366721624877216,['FGF10'],0.9993093490438837,0,0,1
435,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9446605250942007,0.3401869158878505,0.019366721624877216,['BRAF'],0.9993093490438837,0,0,1
436,Metapathway biotransformation Phase I and II WP702,0.9454268405078803,0.5889798380625059,0.03305282429619614,"['GSTZ1', 'CYP26B1', 'CYP24A1', 'GSTA4', 'MGST3', 'AKR1A1', 'HS3ST1']",0.9993093490438837,0,0,7
437,Pathways affected in adenoid cystic carcinoma WP3651,0.9459470798909033,0.475857766687461,0.026442774835423243,"['CHEK1', 'ARID5B', 'DTX4']",0.9993093490438837,0,0,3
438,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9459470798909033,0.475857766687461,0.026442774835423243,"['STMN1', 'PXN', 'NFKB1']",0.9993093490438837,0,0,3
439,DNA IR-damage and cellular response via ATR WP4016,0.9459674646452773,0.5142895704693458,0.028567295780876217,"['FEN1', 'CHEK1', 'CDK1', 'CLSPN']",0.9993093490438837,0,0,4
440,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9498891867404545,0.4139108749864469,0.021279136033000155,"['HOMER1', 'PRKAG1']",0.9993093490438837,0,0,2
441,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9499213985322421,0.3284348479965625,0.016873680639248708,['NFKB1'],0.9993093490438837,0,0,1
442,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.954652902474857,0.5893801360227416,0.0273516335975122,"['TJP1', 'MAP2K4', 'WNT10B', 'WNT10A', 'ZEB1', 'RBBP4', 'PDCD6', 'DLL3']",0.9993093490438837,0,0,8
443,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9546824048318318,0.317466251298027,0.014722990809165613,['NFKB1'],0.9993093490438837,0,0,1
444,Neovascularisation processes WP4331,0.9546824048318318,0.317466251298027,0.014722990809165613,['NFKB1'],0.9993093490438837,0,0,1
445,Fatty acid beta-oxidation WP143,0.9589910124034035,0.30720530599939705,0.012863784723680573,['DECR1'],0.9993093490438837,0,0,1
446,Neural Crest Cell Migration during Development WP4564,0.9589910124034035,0.30720530599939705,0.012863784723680573,['NGEF'],0.9993093490438837,0,0,1
447,TGF-beta Signaling Pathway WP366,0.9609323656935268,0.5590626494500239,0.022279346291986208,"['TGFBR3', 'MAP2K4', 'ZEB1', 'TERT', 'TNC', 'CDK1', 'PDK1']",0.9993093490438837,0,0,7
448,Interferon type I signaling pathways WP585,0.96093584542515,0.3884930530815818,0.015480527585430757,"['RPS6KA5', 'RAP1A']",0.9993093490438837,0,0,2
449,Cardiac Hypertrophic Response WP2795,0.9640681135237964,0.38069825436408977,0.0139310167325752,"['MAP2K4', 'NFKB1']",0.9993093490438837,0,0,2
450,Genotoxicity pathway WP4286,0.9640681135237964,0.38069825436408977,0.0139310167325752,"['RAPGEF2', 'TRIAP1']",0.9993093490438837,0,0,2
451,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9640681135237964,0.38069825436408977,0.0139310167325752,"['WNT10B', 'PPARG']",0.9993093490438837,0,0,2
452,Insulin Signaling WP481,0.9641608682822288,0.5855585386984157,0.021371201707473766,"['MAP2K4', 'EHD2', 'RPS6KA5', 'TBC1D4', 'PRKCB', 'STXBP4', 'PRKCD', 'GAB1', 'IGF1R']",0.9993093490438837,0,0,9
453,Microglia Pathogen Phagocytosis Pathway WP3937,0.9664188062826631,0.28854904182006985,0.009856255818079035,['VAV3'],0.9993093490438837,0,0,1
454,"GPCRs, Class A Rhodopsin-like WP455",0.9670829232877282,0.54520755800244,0.018248660745871195,"['MAS1', 'CCKBR', 'RHO', 'RRH', 'ADRA1D', 'FPR2', 'HTR5A']",0.9993093490438837,0,0,7
455,Neural Crest Cell Migration in Cancer WP4565,0.96961207251623,0.280043980208906,0.008641936755419901,['NGEF'],0.9993093490438837,0,0,1
456,Male infertility WP4673,0.9741025654727817,0.4800345743506268,0.01259547239650039,"['CYP26B1', 'UBE2B', 'CAT', 'HORMAD1', 'SOX5']",0.9993093490438837,0,0,5
457,G13 Signaling Pathway WP524,0.9751169284467411,0.2644513672551056,0.0066636160823924755,['GNA13'],0.9993093490438837,0,0,1
458,Hedgehog Signaling Pathway WP4249,0.9751169284467411,0.2644513672551056,0.0066636160823924755,['CCND2'],0.9993093490438837,0,0,1
459,IL-5 signaling pathway WP127,0.9751169284467411,0.2644513672551056,0.0066636160823924755,['JAK2'],0.9993093490438837,0,0,1
460,Vitamin D-sensitive calcium signaling in depression WP4698,0.9751169284467411,0.2644513672551056,0.0066636160823924755,['SLC8A1'],0.9993093490438837,0,0,1
461,NO/cGMP/PKG mediated Neuroprotection WP4008,0.9815629455420026,0.24406102723859732,0.004541764686684638,['NFKB1'],0.9993093490438837,0,0,1
462,Ebola Virus Pathway on Host WP4217,0.9837264395620774,0.4481279389061082,0.0073526274106754065,"['ITGAV', 'EIF2S1', 'NFKB1', 'IGF1R', 'ACTG1']",0.9993093490438837,0,0,5
463,Amino Acid metabolism WP3925,0.9838077954672247,0.37528318613126704,0.006126396994477004,"['WARS', 'MDH2', 'PYCR1']",0.9993093490438837,0,0,3
464,Ectoderm Differentiation WP2858,0.9845937513578656,0.4709194214876033,0.00731156936895259,"['ABCC4', 'ARHGEF9', 'EDA', 'ZBTB16', 'NF2', 'CAP2']",0.9993093490438837,0,0,6
465,Endometrial cancer WP4155,0.9846323671677013,0.3170407315045719,0.004909990399581531,"['BRAF', 'FGF1']",0.9993093490438837,0,0,2
466,Interleukin-11 Signaling Pathway WP2332,0.9863396978117647,0.22658359293873312,0.003116535556209945,['JAK2'],0.9993093490438837,0,0,1
467,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9863396978117647,0.22658359293873312,0.003116535556209945,['MAP1LC3A'],0.9993093490438837,0,0,1
468,Melanoma WP4685,0.9870669034269282,0.3067733891078755,0.003993409468593177,"['BRAF', 'CALM3']",0.9993093490438837,0,0,2
469,Androgen receptor signaling pathway WP138,0.989050378541569,0.35200203322474066,0.0038755458310720577,"['NCOA1', 'BAG1', 'DSTN']",0.9993093490438837,0,0,3
470,Regulation of toll-like receptor signaling pathway WP1449,0.9906807800810086,0.3837879418403763,0.0035933740822330896,"['MAP2K4', 'PELI2', 'SQSTM1', 'NFKB1']",0.9993093490438837,0,0,4
471,Mesodermal commitment pathway WP2857,0.9912138606741066,0.41281264427124353,0.0036430571513020797,"['VAV3', 'SESN1', 'ARID5B', 'JAK2', 'TEAD1']",0.9993093490438837,0,0,5
472,Allograft Rejection WP2328,0.9932153465676061,0.19412550066755674,0.001321562502937821,['GNLY'],0.9993093490438837,0,0,1
473,Toll-like Receptor Signaling Pathway WP75,0.9935588548834667,0.271571072319202,0.0017548865125046455,"['MAP2K4', 'NFKB1']",0.9993093490438837,0,0,2
474,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9954519159503252,0.17942749662023158,0.0008179127164384902,['CHEK1'],0.9993093490438837,0,0,1
475,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9977876086447603,0.32158953850060307,0.0007122701158871578,"['MAP2K4', 'RPS6KA5', 'PRKAG1', 'RICTOR']",0.9993093490438837,0,0,4
476,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9990809594214287,0.13767664454377174,0.00012658860200247336,['BRAF'],0.9993093490438837,0,0,1
477,22q11.2 copy number variation syndrome WP4657,0.9993093490438837,0.19977687360546004,0.00013802375737386244,"['CYP26B1', 'FGF10']",0.9993093490438837,0,0,2
